原著論文

1. Kazutaka Nogi, Tomoya Ueda, Takuya Nakamura, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Ayako Seno, Kenji Onoue, Makoto Watanabe, Yoshihiko Saito New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure - PubMed (nih.gov)
J Am Heart Assoc . 2023 Jan

2.

Koshiro Kanaoka, Yoshitaka Iwanaga, Katsuki Okada, Satoshi Terasaki, Yuichi Nishioka, Michikazu Nakai, Daisuke Kamon, Tomoya Myojin, Tsunenari Soeda, Tatsuya Noda, Manabu Horii, Yasushi Sakata, Yoshihiro Miyamoto, Yoshihiko Saito, Tomoaki Imamura. Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims.
Validity of Diagnostic Algorithms for Cardiovascular Diseases in Japanese Health Insurance Claims - PubMed (nih.gov)
Circulation Journal. 2023:87(4);536-542

3.

Kanaoka K, Iwanaga Y, Nakai M, Sumita Y, Saito Y, Miyamoto Y.
Temporal Trends and Regional Variations in Cardiovascular Care in Japan, 2010-2019.
Temporal Trends and Regional Variations in Cardiovascular Care in Japan, 2010-2019 - PubMed (nih.gov)
Int Heart J. 2023 Jan.

4.

Atsushi Kyodo, Koshiro Kanaoka, Ayaka Keshi, Maki Nogi, Kazutaka Nogi, Satomi Ishihara, Daisuke Kamon, Yukihiro Hashimoto, Yasuki Nakada, Tomoya Ueda, Ayako Seno, Taku Nishida, Kenji Onoue, Tsuneari Soeda, Rika Kawakami, Makoto Watanabe, Toshiyuki Nagai, Toshihisa Anzai, Yoshihiko Saito.
Heart failure with preserved ejection fraction phenogroup classification using machine learning - PubMed (nih.gov)
ESC Heart Fail. 2023 Apr 12.

5.

Azusa Sakagami, Tsunenari Soeda, Yoshihiko Saito, Koichi Nakao, Yukio Ozaki, Kazuo Kimura, Junya Ako, Teruo Noguchi, Satoru Suwa, Kazuteru Fujimoto, Kazuoki Dai, Takashi Morita, Wataru Shimizu, Atsushi Hirohata, Yasuhiro Morita, Teruo Inoue, Atsunori Okamura, Toshiaki Mano, Minoru Wake, Kengo Tanabe, Yoshisato Shibata, Mafumi Owa, Kenichi Tsujita, Hiroshi Funayama, Nobuaki Kokubu, Ken Kozuma, Shiro Uemura, Tetsuya Tobaru, Keijiro Saku, Shigeru Oshima, Yoshihiro Miyamoto, Hisao Ogawa, Masaharu Ishihara; J-MINUET investigators.
Clinical impact of beta-blockers at discharge on long-term clinical outcomes in patients with non-reduced ejection fraction after acute myocardial infarction - PubMed (nih.gov)
J Cardiol. 2023 Jan;81(1):83-90.

6.

Takuya Nakamura, Makoto Watanabe, Kazutaka Nogi, Takaaki Kosugi, Yukihiro Hashimoto, Tomoya Ueda, Naofumi Doi, Hiroyuki Kawata, Manabu Horii, Kenichi Ishigami, Tamio Nakajima, Hiroaki Watabe, Daisuke Abe, Koichiro Kuwahara, Yasuo Okumura, Naoki Ozu, Shota Suzuki, Shu Kasama, Yoshihiko Saito
Prevention of Contrast-Induced Nephropathy After Emergency Percutaneous Coronary Intervention With a Single Bolus Administration of High-Concentrate Sodium Bicarbonate - Rationale and Design of a Single-Arm Study Compared With Historical Controls - PubMed (nih.gov)
Circ Rep. 2023 Mar 9;5(4):152-156.

7.

Kazutaka Nogi, Ryohei Yamamoto, Tomoya Ueda, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Yukihiro Hashimoto, Hitoshi Nakagawa, Taku Nishida, Ayako Seno, Kenji Onoue, Makoto Watanabe, Norihide Takaya, Izuru Masuda, Yoshihiko Saito
Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure - PubMed (nih.gov)
J Cardiol. 2023 May 27;S0914-5087(23)00126-0.

1. Kanaoka K, Nishida T, Nishioka Y, Myojin T, Kubo S, Soeda T, Okada K, Noda T, Iwanaga Y, Miyamoto Y, Sakata Y, Imamura T, Saito Y.
The impact of hospital case volume on the outcomes after catheter ablation for atrial fibrillation according to the ablation technology - PubMed (nih.gov)
J Cardiovasc Electrophysiol. 2022 Jul.

2. Kanaoka K, Iwanaga Y, Tsujimoto Y, Shiroshita A, Suzuki T, Nakai M, Miyamoto Y.
Quality indicators for acute cardiovascular diseases: a scoping review - PubMed (nih.gov)
BMC Health Serv Res. 2022 Jul.

3. Kanaoka K, Iwanaga Y, Nakai M, Nishioka Y, Myojin T, Kubo S, Okada K, Soeda T, Noda T, Sakata Y, Miyamoto Y, Saito Y, Imamura T.
Outpatient cardiac rehabilitation dose after acute coronary syndrome in a nationwide cohort - PubMed (nih.gov)
Heart. 2022 Mar 3.

4. Ishihara S, Hiramitsu S, Kanaoka K, Taki M, Nakagawa H, Ueda T, Seno A, Nishida T, Onoue K, Soeda T, Ohtani T, Watanabe M, Kawakami R, Sakata Y, Kario K, Saito Y.
New Conversion Formula Between B-Type Natriuretic Peptide and N-Terminal-Pro-B-Type Natriuretic Peptide - Analysis From a Multicenter Study - PubMed (nih.gov)
Circ J. 2022 May 25.

5. Nakano T, Onoue K, Terada C, Terasaki S, Ishihara S, Hashimoto H, Nakada Y, Nakagawa h, Ueda T, Seno A, Nishida T, Watanabe M, Hoshii Y, Hatakeyama K, Sakaguchi Y, Ohbayashi C, Saito Y.
Transthyretin Amyloid Cardiomyopathy: Impact of Transthyretin Amyloid Deposition in Myocardium on Cardiac Morphology and Function - PubMed (nih.gov)
J Pers Med. 2022 May 1.

6. Nogi K, Ueda T, Matsue Y, Nogi M, Ishihara S, Nakada Y, Kawakami R, Kagiyama N, Kitai T, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Saito Y.
Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure.
ESC Heart Fail. 2022 Feb 4.

7. Terasaki S, Kanaoka K, Nakai M, Sumita Y, Onoue K, Soeda T, Watanabe M, Miyamoto Y, Saito Y.
Outcomes of catecholamine and/or mechanical support in Takotsubo syndrome.
Heart. 2022 Jan 19:heartjnl-2021-319904.

8. Okamura A, Okura H, Iwai S, Kyodo A, Kamon D, Hashimoto Y, Ueda T, Soeda T, Watanabe M, Saito Y.
Detection of myocardial bridge by optical coherence tomography.
Int J Cardiovasc Imaging. 2022 Jan 1

9. Kyodo A, Okura H, Okamura A, Iwai S, Kamon D, Hashimoto Y, Ueda T, Soeda T, Watanabe M, Saito Y.
Incidence and characteristics of incomplete stent apposition in calcified lesions: An optical coherence tomography study.
Cardiovasc Revasc Med. 2022 Jan 4:S1553-8389(21)00833-2.

10. Nakagawa H, Saito Y.
Roles of Natriuretic Peptides and the Significance of Neprilysin in Cardiovascular Diseases - PubMed (nih.gov)
Biology (Basel). 2022 Jul.

11. Junichi Sugiura, Makoto Watanabe, Saki Nobuta, Akihiko Okamura, Atsushi Kyodo, Takuya Nakamura, Kazutaka Nogi, Satomi Ishihara, Yukihiro Hashimoto, Tomoya Ueda, Ayako Seno, Kenji Onoue, Tsunenari Soeda, Yoshihiko Saito
Prediction of optical coherence tomography-detected calcified nodules using coronary computed tomography angiography - PubMed (nih.gov)
Sci Rep. 2022 Dec

12. Yukihiro Hashimoto, Tsunenari Soeda, Ayako Seno, Satoshi Okayama, Nozomi Fukuda, Hiroki Yano, Atsushi Iwai, Kazutaka Nogi, Kaeko Hirai, Hajime Fujimoto, Megumi Suzuki, Hajime Iwama, Takehito Nakai, Naofumi Doi, Yoshihiko Saito
Reverse Remodeling and Non-Contrast T1 Hypointense Infarct Core in Patients With Reperfused Acute Myocardial Infarction - PubMed (nih.gov)
Circ J. 2022 Nov

13. Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki, Tomoya Nakano, Michikazu Nakai, Yoko Sumita, Kinta Hatakeyama, Fumio Terasaki, Rika Kawakami, Yoshitaka Iwanaga, Yoshihiro Miyamoto, Yoshihiko Saito; Japanese Registry of Fulminant Myocarditis Investigators
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation - PubMed (nih.gov)
Circulation . 2022 Nov

14.

Kanaoka K, Iwanaga Y, Nakai M, Nishioka Y, Myojin T, Kubo S, Okada K, Soeda T, Noda T, Sakata Y, Miyamoto Y, Saito Y, Imamura T.
Hospital- and Patient-Level Analysis of Quality Indicators in Acute Coronary Syndrome Care: A Nationwide Database Study - PubMed (nih.gov)
Can J Cardiol. 2022 Dec 8;S0828-282X(22)01057-1.

15.

Kanaoka K, Iwanaga Y, Nakai M, Nishioka Y, Myojin T, Kubo S, Okada K, Noda T, Sakata Y, Miyamoto Y, Saito Y, Imamura T.
Multifactorial Effects of Outpatient Cardiac Rehabilitation in Patients with Heart Failure: A Nationwide Retrospective Cohort Study - PubMed (nih.gov)
Eur J Prev Cardiol. 2022 Nov 15: zwac274.

16.

Kanaoka K, Iwanaga Y, Fukuma N, Nakai M, Sumita Y, Nishioka Y, Okada K, Noda T, Sakata Y, Imamura T, Miyamoto Y.
Trends and Factors Associated With Cardiac Rehabilitation Participation - Data From Japanese Nationwide Databases - PubMed (nih.gov)
Circ J. 2022 Nov 25;86(12):1998-2007.

17.

Nishida T, Takitsume A, Sugiura J, Keshi A, Kanaoka K, Hirai K, Yano H, Hashimoto Y, Ueda T, Nakagawa H, Onoue K, Soeda T, Watanabe M, Kawakami R, Saito Y.
Catheter ablation of ganglionated plexi in patients with adenosine triphosphate-induced atrial fibrillation after pulmonary vein isolation - PubMed (nih.gov)
Heart Vessels. 2022 May;37(5):854-866.

18.

Matsui M, Onoue K, Saito Y.
sFlt-1 in Chronic Kidney Disease: Friend or Foe? - PubMed (nih.gov)
Int J Mol Sci. 2022 Nov 16;23(22):14187.

19.

Okamura A, Okura H, Iwai S, Sakagami A, Kamon D, Hashimoto Y, Ueda T, Soeda T, Watanabe M, Saito Y.
Incidence and prognostic impact of the calcified nodule in coronary artery disease patients with end-stage renal disease on dialysis - PubMed (nih.gov)
Heart Vessels. 2022 Oct;37(10):1662-1668.

20.

Okamura A, Yoshioka Y, Saito Y, Ochiya T.
Can Extracellular Vesicles as Drug Delivery Systems Be a Game Changer in Cardiac Disease? - PubMed (nih.gov)
Pharm Res. 2022 Dec 28.

21.

Onoue K, Nakano T, Akai Y, Sakaguchi Y, Saito Y.
Mass Spectrometric Comparison of the Cardiac Globotriaosylceramide Profile in 5 Patients With Fabry's Disease - PubMed (nih.gov)
Circ J. 2022 Dec 23;87(1):154.

22.

Watanabe M.
Prediction of Persistent Renal Dysfunction Following Contrast-Induced Nephropathy After Cardiac Catheterization Procedures - PubMed (nih.gov)
Circ J. 2022 Nov 15.

1.

Antiochos P, Ge Y, van der Geest RJ, Madamanchi C, Qamar I, Seno A, Jerosch-Herold M, Tedrow UB, Stevenson WG, Kwong RY.
Entropy as a Measure of Myocardial Tissue Heterogeneity in Patients With Ventricular Arrhythmias - PubMed (nih.gov)
JACC Cardiovasc Imaging. 15. 783-792. 2022.

2.

Kinugasa Y, Nakamura K, Kamitani H, Hirai M, Yanagihara K, Kato M, Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Anzai T.
Left ventricular mass index-to-QRS-voltage ratio predicts outcomes in heart failure with preserved ejection fraction - PubMed (nih.gov)
ESC Heart Fail. 2022 Jan 25.

3.

Konishi M, Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H;
Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators.
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease - PubMed (nih.gov)
Int J Cardiol. 2022 Feb 15;349:127-133

4.

Kusano K, Yamane T, Inoue K, Takegami M, Nakao YM, Nakai M, Kanaoka K, Tonegawa-Kuji R, Miyamoto K, Iwasaki YK, Takatsuki S, Nakamura K, Iwanaga Y, Shimizu W;
J‐AB registry investigators.
The Japanese Catheter Ablation Registry (J-AB): Annual report in 2020 - PubMed (nih.gov)
J Arrhythm. 2022 Aug 27;38(5):675-681.

5.

Kuriyama N, Yoshioka Y, Kikuchi S, Okamura A, Azuma N, Ochiya T.
Challenges for the Development of Extracellular Vesicle-Based Nucleic Acid Medicines - PubMed (nih.gov)
Cancers (Basel). 2021 Dec 6;13(23):6137.

5.

Misumi K, Matsue Y, Nogi K, Sunayama T, Dotare T, Maeda D, Kagiyama N, Kasai T, Kitai T, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Nogi M, Ishihara S, Ueda T, Kawakami R, Saito Y, Minamino T.
Usefulness of Incorporating Hypochloremia into the Get With The Guidelines-Heart Failure Risk Model in Patients With Acute Heart Failure - PubMed (nih.gov)
Am J Cardiol. 2022 Jan 1;162:122-128.

6.

Miura K, Matsuura K, Yamasaki Itoyama Y, Sasaki D, Takada T, Furutani Y, Hayama E, Ito M, Nomura S, Morita H, Toyoda M, Umezawa A, Onoue K, Saito Y, Aburatani H, Nakanishi T, Hagiwara N, Komuro I, Shimizu T.
Functional Evaluation of Human Bioengineered Cardiac Tissue Using iPS Cells Derived from a Patient with Lamin Variant Dilated Cardiomyopathy - PubMed (nih.gov)
Int Heart J. 2022;63(2):338-346.

7.

Miyamoto K, Kanaoka K, Yoh M, Takahashi H, Kishihara J, Ishikura M, Sasaki Y, Fukunaga H, Nagase T, Asano S, Mizuno S, Yamagami S, Yazaki Y, Kusume T, Takada Y, Yodogawa K, Shimizu W, Shigeta T, Sagawa Y, Inoue Y, Nagase S, Aiba T, Takagi M, Fukaya H, Kobori A, Nitta J, Murakami M, Nishiuchi S, Satomi K, Kataoka N, Iwasaki YK, Ashikaga K, Yamauchi Y, Kusano K.
Cryoballoon Ablation versus Radiofrequency Ablation in Patients with Persistent Atrial Fibrillation (CRRF-PeAF): Protocol for a Prospective, Multicenter, Randomized, Controlled Study - PubMed (nih.gov)
Int J Cardiol Heart Vasc. 2022 Jun 25;41:101074.

8.

Nakai M, Iwanaga Y, Kanaoka K, Sumita Y, Nishioka Y, Myojin T, Kubo S, Okada K, Soeda T, Noda T, Sakata Y, Imamura T, Saito Y, Yasuda S, Miyamoto Y.
Age-dependent association of discharge heart-failure medications with clinical outcomes in a super-aged society - PubMed (nih.gov)
Biomed Pharmacother. 2022 Nov;155:113761.

9.

Nakai M, Iwanaga Y, Kanaoka K, Sumita Y, Nishioka Y, Myojin T, Kubo S, Okada K, Soeda T, Noda T, Sakata Y, Imamura T, Saito Y, Yasuda S, Miyamoto Y.
Contemporary use of SGLT2 inhibitors in heart failure patients with diabetes mellitus: a comparison of DPP4 inhibitors in a nationwide electric health database of the superaged society - PubMed (nih.gov)
Cardiovasc Diabetol. 2022 Aug 13;21(1):157.

10.

Ogawa Y, Yamana H, Noda T, Kishimoto M, Yoshihara S, Kanaoka K, Matsui H, Fushimi K, Yasunaga H, Kawaguchi M, Imamura T.
Severe Complications after General Anesthesia versus Sedation during Pediatric Diagnostic Cardiac Catheterization for Ventricular Septal Defect - PubMed (nih.gov)
J Clin Med. 2022 Aug 31;11(17):5165.

11.

Ogawa M, Yoshida N, Nakai M, Kanaoka K, Sumita Y, Kanejima Y, Emoto T, Saito Y, Yamamoto H, Sakai Y, Hirota Y, Ogawa W, Iwanaga Y, Miyamoto Y, Yamashita T, Izawa KP, Hirata KI.
Hospital-associated disability and hospitalization costs for acute heart failure stratified by body mass index- insight from the JROAD/JROAD-DPC database - PubMed (nih.gov)
Int J Cardiol. 2022 Nov 15;367:38-44.

12.

Onishi T, Shimonishi N, Takeyama M, Furukawa S, Ogiwara K, Nakajima Y, Kasahara K, Nishio K, Yoshimoto K, Inoue S, Kawaguchi M, Fukushima H, Saito Y, Yoshiji H, Muro S, Tsuruya K, Okada S, Sugie K, Kawaguchi R, Nishikubo T, Yamazaki M, Oda Y, Kawabe T, Onishi K, Nishio T, Nogami K
The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19 - PubMed (nih.gov)
Int J Hematol. 2022 Feb 16:1-12.

13.

Sasaki S, Nishihira K, Yamashita A, Fujii T, Onoue K, Saito Y, Hatakeyama K, Shibata Y, Asada Y, Ohbayashi C.
Involvement of enhanced expression of classical complement C1q in atherosclerosis progression and plaque instability: C1q as an indicator of clinical outcome - PubMed (nih.gov)
PLoS One. 2022 Jan 27;17(1):e0262413.

14.

Terada CI, Onoue K, Fujii T, Itami H, Morita K, Uchiyama T, Takeda M, Nakagawa H, Nakano T, Baba Y, Amemiya K, Saito Y, Hatakeyama K, Ohbayashi C.
Histopathological and epigenetic changes in myocardium associated with cancer therapy-related cardiac dysfunction - PubMed (nih.gov)
ESC Heart Fail. 2022 Oct;9(5):3031-3043.

15.

Tonegawa-Kuji R, Kanaoka K, Iwanaga Y.
Current status of real-world big data research in the cardiovascular field in Japan - PubMed (nih.gov)

J Cardiol. 2022 Sep 17:S0914-5087(22)00229-5.

16.

Tonegawa-Kuji R, Kanaoka K, Mori M, Nakai M, Iwanaga Y.
Mortality and 30-Day Readmission Rates After Inpatient Leadless Pacemaker Implantation: Insights From a Nationwide Readmissions Database - PubMed (nih.gov)
Can J Cardiol. 2022 Nov;38(11):1697-1705.

17.

Tonegawa-Kuji R, Inoue YY, Nakai M, Kanaoka K, Sumita Y, Miyazaki Y, Wakamiya A, Shimamoto K, Ueda N, Wada M, Yamagata K, Ishibashi K, Miyamoto K, Nagase S, Aiba T, Iwanaga Y, Miyamoto Y, Kusano K.
Current clinical practice of subcutaneous implantable cardioverter-defibrillator: Analysis using the JROAD-DPC database - PubMed (nih.gov)
Heart Rhythm. 2022 Jun;19(6):909-916.

18.

Yoshida N, Ogawa M, Nakai M, Kanaoka K, Sumita Y, Emoto T, Saito Y, Yamamoto H, Izawa KP, Sakai Y, Hirota Y, Ogawa W, Iwanaga Y, Miyamoto Y, Yamashita T, Hirata KI.
Impact of body mass index on in-hospital mortality for six acute cardiovascular diseases in Japan - PubMed (nih.gov)
Sci Rep. 2022 Nov 7;12(1):18934.

1. Iwai S, Watanabe M, Okamura A, Kyodo A, Nogi K, Kamon D, Hashimoto Y, Ueda T, Soeda T, Okura H, Saito Y.
Prognostic Impact of Calcified Plaque Morphology After Drug Eluting Stent Implantation　- An Optical Coherence Tomography Study.
Circ J. 2021 May 27. PMID: 34039823.

2. Ueda T, Kasama S, Yamamoto M, Nakano T, Ueshima K, Morikawa Y, Kawata H, Yoshihisa A, Nakayama M, Komatsu S, Soeda T, Watanabe M, Kawakami R, Okada Y, Tanaka H, Susuta Y, Kasahara M, Tsujita K, Takeishi Y, Saito Y; CANONICAL Study Group.
Effect of the Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin for Heart Failure With Preserved Ejection Fraction in Patients With Type 2 Diabetes.
Circ Rep. 2021 Jul 22;3(8):440-448.

3. Ueda T, Kawakami R, Nogi K, Nogi M, Ishihara S, Nakada Y, Nakano T, Hashimoto Y, Nakagawa H, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Saito Y.
Serum iron: a new predictor of adverse outcomes independently from serum hemoglobin levels in patients with acute decompensated heart failure.
Sci Rep. 2021 Jan 27;11(1):2395.

4. Okura H, Nakada Y, Nogi M, Ishihara S, Okamura A, Okayama S, Watanabe M, Kawakami R, Saito Y.
Prevalence of mitral annular calcification and its association with mitral valvular disease.
Echocardiography. 2021 Oct 30.

5. Okura H, Watanabe M, Miura A, Kurokawa M, Ueda T, Soeda T, Saito Y.
Comparison of quantitative measurements between two different intravascular ultrasound catheters and consoles: in vitro and in vivo studies.
Cardiovasc Interv Ther. 2021 Feb 27.

6. Onoue K, Nakagawa H, Keshi A, Sugiura J, Okamura A, Kanaoka K, Kyodo A, Terasaki S, Nakamura T, Yano H, Nogi K, Ishihara S, Hashimoto Y, Ueda T, Seno A, Nishida T, Soeda T, Watanabe M, Kawakami R, Saito Y.
Overview of the 85th Annual Scientific Meeting of the Japanese Circulation Society　- NEXT STAGE; Future of Medicine and Community.
Circ J. 2021 Oct 6.

7. Onoue K, Wakimoto H, Jiang J, Parfenov M, DePalma S, Conner D, Gorham J, McKean D, Seidman JG, Seidman CE, Saito Y.
Cardiomyocyte Proliferative Capacity Is Restricted in Mice With Lmna Mutation.
Front Cardiovasc Med. 2021 Jun 23;8:639148.

8. Onoue K, Saito Y.
New treatment for myocardial diseases.
J Cardiol. 2021 Jun;77(6):620-625.

9. Kanaoka K, Soeda T, Terasaki S, Nishioka Y, Myojin T, Kubo S, Okada K, Noda T, Watanabe M, Kawakami R, Sakata Y, Imamura T, Saito Y.
Current Status and Effect of Outpatient Cardiac Rehabilitation After Percutaneous Coronary Intervention in Japan.
Circ Rep. 2021 Feb 27;3(3):122-130.

10. Kawakami R, Nakada Y, Hashimoto Y, Ueda T, Nakagawa H, Nishida T, Onoue K, Soeda T, Watanabe M, Saito Y.
Prevalence and Prognostic Significance of Pulmonary Function Test Abnormalities in Hospitalized Patients With Acute Decompensated Heart Failure With Preserved and Reduced Ejection Fraction.
Circ J. 2021 Apr 16. PMID: 33867406.

11. Kyodo A, Soeda T, Okamura A, Iwai S, Sakagami A, Nogi K, Kamon D, Hashimoto Y, Ueda T, Watanabe M, Saito Y.
Clinical Impact of Irregular Protrusion Angle After Coronary Stenting at Culprit Lesions With ST-Elevation Myocardial Infarction　- An Intravascular Optical Coherence Tomography Study.
Circ Rep. 2021 Jul 9;3(8):431-439.

12. Kyodo A, Watanabe M, Okamura A, Iwai S, Sakagami A, Nogi K, Kamon D, Hashimoto Y, Ueda T, Soeda T, Okura H, Saito Y.
Post-Stent Optical Coherence Tomography Findings at Index Percutaneous Coronary Intervention　- Characteristics Related to Subsequent Stent Thrombosis.
Circ J. 2021 Jan 27.

13. Sugiura, J. Soeda, T, Kyodo, A. Nakamura, T. Okamura, A. Nogi, K. Hashimoto, Y. Ueda, T. Watanabe, M. Saito, Y.
Clinical Course of Optical Coherence Tomography-Detected Lipid-rich Coronary Plaque after Optimal Medical Therapy
Circulation Reports. 2021 Dec 3;4(1):29-37.

14. Nakagawa H, Kumazawa T, Onoue K, Nakada Y, Nakano T, Ishihara S, Minamino N, Hosoda H, Iwata N, Ueda T, Seno A, Nishida T, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
Local Action of Neprilysin Exacerbates Pressure Overload Induced Cardiac Remodeling.
Hypertension. 2021 Jun;77(6):1931-1939.

15. Nakano T, Onoue K, Seno A, Ishihara S, Nakada Y, Nakagawa H, Ueda T, Nishida T, Soeda T, Watanabe M, Kawakami R, Hatakeyama K, Sakaguchi Y, Ohbayashi C, Saito Y.
Involvement of chronic inflammation via monocyte chemoattractant protein-1 in uraemic cardiomyopathy: a human biopsy study.
ESC Heart Fail. 2021 May 14. PMID: 33988313.

16. Nishida T, Takitsume A, Sugiura J, Keshi A, Kanaoka K, Hirai K, Yano H, Hashimoto Y, Ueda T, Nakagawa H, Onoue K, Soeda T, Watanabe M, Kawakami R, Saito Y.
Catheter ablation of ganglionated plexi in patients with adenosine triphosphate-induced atrial fibrillation after pulmonary vein isolation.
Heart Vessels. 2021 Nov 6.

17. Nogi K, Soeda T, Hara M, Iwama H, Toyokawa N, Sakai S, Yano H, Iwai A, Hashimoto Y, Fujimoto H, Suzuki M, Nakai T, Doi N, Saito Y.
Functional assessment of intermediate coronary artery stenosis with 4-Fr catheters.
Heart Vessels. 2021 May;36(5):638-645.

18. Nogi K, Kawakami R, Ueda T, Nogi M, Ishihara S, Nakada Y, Hashimoto Y, Nakagawa H, Nishida T, Seno A, Onoue K, Soeda T, Watanabe M, Saito Y.
Prognostic Value of Fractional Excretion of Urea Nitrogen at Discharge in Acute Decompensated Heart Failure.
J Am Heart Assoc. 2021 Aug 17;10(16)

19. Fujimoto H, Doi N, Okayama S, Naito M, Kobori A, Kaitani K, Inoue K, Kurotobi T, Morishima I, Yamaji H, Matsui Y, Nakazawa Y, Kusano K, Hirai K, Nakai T, Suzuki M, Yano H, Sakai S, Kimura T, Shizuta S, Saito Y.
Long-term prognosis of patients undergoing radiofrequency catheter ablation for atrial fibrillation: comparison between heart failure subtypes based on left ventricular ejection fraction.
Europace. 2021 Aug 31.

20. Kaeko Hirai, Rika Kawakami, Maki Nogi, Satomi Ishihara, Yukihiro Hashimoto, Yasuki Nakada, Hitoshi Nakagawa, Tomoya Ueda, Taku Nishida, Kenji Onoue, Tsunenari Soeda, Satoshi Okayama, Makoto Watanabe, Hiroyuki Okura, Yoshihiko Saito.
Impact of Atrial Fibrillation on the Prognosis of Acute Decompensated Heart Failure With and Without Mitral Regurgitation.
Circ Rep. 2021 Jul. Vol.3 No.7 388 - 395.

21. Morikawa Y, Kawakami R, Horii M, Yamamoto Y, Yabuta M, Saito Y.
Handgrip Strength Is an Independent Predictor of Cardiovascular Outcomes in Diabetes Mellitus.
Int Heart J. 2021;62(1):50-56.

22. Hiroki Yano, Taku Nishida, Junichi Sugiura, Ayaka Keshi, Koshiro Kanaoka, Satoshi Terasaki, Yukihiro Hashimoto, Yasuki Nakada, Hitoshi Nakagawa, Tomoya Ueda, Ayako Seno, Kenji Onoue, Makoto Watanabe, Yoshihiko Saito.
Incidence of epicardial connections between the right pulmonary vein carina and right atrium during catheter ablation of atrial fibrillation: A comparison between the conventional method and unipolar signal modification.
Journal of Arrhythmia. 27 December 2021

1. Anzai T, Sato T, Fukumoto Y, Izumi C, Kizawa Y, Koga M, Nishimura K, Ohishi M, Sakashita A, Sakata Y, Shiga T, Takeishi Y, Yasuda S, Yamamoto K, Abe T, Akaho R, Hamatani Y, Hosoda H, Ishimori N, Kato M, Kinugasa Y, Kubozono T, Nagai T, Oishi S, Okada K, Shibata T, Suzuki A, Suzuki T, Takagi M, Takada Y, Tsuruga K, Yoshihisa A, Yumino D, Fukuda K, Kihara Y, Saito Y, Sawa Y, Tsutsui H, Kimura T; Japanese Circulation Society Joint Working Group.
JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases.
Circ J. 2021 Apr 23;85(5):695-757. PMID: 33775980

2. Ishii M, Seki T, Kaikita K, Sakamoto K, Nakai M, Sumita Y, Nishimura K, Miyamoto Y, Noguchi T, Yasuda S, Kanaoka K, Terasaki S, Saito Y, Tsutsui H, Komuro I, Ogawa H, Tsujita K, Kawakami K; JROAD Investigators.
Association of short-term exposure to air pollution with myocardial infarction with and without obstructive coronary artery disease.
Eur J Prev Cardiol. 2021 Oct 25;28(13):1435-1444.

3. Okuno K, Naito Y, Asakura M, Sugahara M, Horimatsu T, Yasumura S, Tahara S, Nagai T, Saito Y, Yoshikawa T, Masuyama T, Ishihara M, Anzai T.
Anemia has an impact on prognosis in heart failure with preserved ejection fraction with mild chronic kidney disease.
Int J Cardiol Heart Vasc. 2021 May 20;34:100796.

4. Kinugasa-Katayama Y, Watanabe Y, Hisamitsu T, Arima Y, Liu NM, Tomimatsu A, Harada Y, Arai Y, Urasaki A, Kawamura T, Saito Y, Nakagawa O.
Tmem100-BAC-EGFP mice to selectively mark and purify embryonic endothelial cells of large caliber arteries in mid-gestational vascular formation.
Genesis. 2021 Mar 2:e23416.

5. Kojima S, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Hiramitsu S, Waki M, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Sugawara M, Mori H, Tsujita K, Matsui K, Hisatome I, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators.
Optimal uric acid levels by febuxostat treatment and cerebral, cardiorenovascular risks: post hoc analysis of a randomised controlled trial.
Rheumatology (Oxford). 2021 Oct 4:keab739.

6. Jackson AM, Jhund PS, Anand IS, Düngen HD, Lam CSP, Lefkowitz MP, Linssen G, Lund LH, Maggioni AP, Pfeffer MA, Rouleau JL, Saraiva JFK, Senni M, Vardeny O, Wijkman MO, Yilmaz MB, Saito Y, Zile MR, Solomon SD, McMurray JJV.
Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction.
Eur Heart J. 2021 Sep 21;42(36):3741-3752.

7. Tada A, Nagai T, Omote K, Iwano H, Tsujinaga S, Kamiya K, Konishi T, Sato T, Komoriyama H, Kobayashi Y, Takenaka S, Mizuguchi Y, Sato T, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry.
Int J Cardiol. 2021 Nov 1;342:43-48.

8. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI.
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
J Card Fail. 2021 Sep 28:S1071-9164(21)00208-6.

9. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI; Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group.
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Circ J. 2021 Sep 29.

10. Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, Desai AS, Ohishi T, Iimori T, Kitamura T, Guo W; PARALLEL-HF Investigators.
Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction　- Results From the PARALLEL-HF Study.
Circ J. 2021 Mar 16.

11. Nakao K, Yasuda S, Noguchi T, Sumita Y, Nakao YM, Nishimura K, Nakai M, Miyamoto Y, Tsutsui H, Saito Y, Komuro I, Gale CP, Ogawa H.
Association of hospital performance measures with readmissions for patients with heart failure: A report from JROAD-DPC study.
Int J Cardiol. 2021 Oct 1;340:48-54.

12. Hashimoto Y, Ozaki Y, Kan S, Nakao K, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Dai K, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Yasuda S, Ismail TF, Muramatsu T, Izawa H, Takahashi H, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET Investigators.
Impact of Chronic Kidney Disease on In-Hospital and 3-Year Clinical Outcomes in Patients With Acute Myocardial Infarction Treated by Contemporary Percutaneous Coronary Intervention and Optimal Medical Therapy　- Insights From the J-MINUET Study.
Circ J. 2021 Jun 3.

13. Hashimoto T, Minami Y, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET Investigators.
Validation of the atherothrombotic risk score for secondary prevention in patients with acute myocardial infarction: the J-MINUET study.
Heart Vessels. 2021 Apr 21.

14. Volpe M, Bauersachs J, Bayés-Genís A, Butler J, Cohen-Solal A, Gallo G, Deichl AS, Khan MS, Battistoni A, Pieske B, Saito Y, Zieroth S.
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence.
Int J Cardiol. 2021 Mar 15;327:138-145.

15. Misumi K, Matsue Y, Nogi K, Sunayama T, Dotare T, Maeda D, Kagiyama N, Kasai T, Kitai T, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Nogi M, Ishihara S, Ueda T, Kawakami R, Saito Y, Minamino T.
Usefulness of Incorporating Hypochloremia into the Get With The Guidelines-Heart Failure Risk Model in Patients With Acute Heart Failure.
Am J Cardiol. 2021 Nov 8

16. Mizuno A, Matsumoto C, Yoneoka D, Kishi T, Ishida M, Sanada S, Fukuda M, Saito Y, Yamauchi-Takihara K, Tsutsui H, Fukuda K, Komuro I, Node K.
Cardiology Department Practices in the First Wave of the Coronavirus Disease Pandemic　- A Nationwide Survey in Japan by the Japanese Circulation Society.
Circ Rep. 2021 Feb 5;3(3):137-141.

17. Wada H, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.
Int Heart J. 2021 May 29;62(3):520-527.

1. Ishihara S. Kawakami R. Nogi M. Hirai K. Hashimoto Y. Nakada Y. Nakagawa H. Ueda T. Nishida T. Onoue K. Soeda T. Okayama S. Watanabe M. Saito Y.
Incidence and Clinical Significance of 30-day and 90-day Rehospitalization for Heart Failure among Patients with Acute Decompensated Heart Failure in Japan: From the NARA-HF Study.
Circ J. 2020 Jan 24;84(2):194-202.

2. Koshiro Kanaoka, Satoshi Okayama,  Satoshi Terasaki, Tomoya Nakano, Masanobu Ishii, Michikazu Nakai, Kenji Onoue, Kunihiro Nishimura, Satoshi Yasuda, Kenichi Tsujita, Rika Kawakami, Yoshihiro Miyamoto, Hiroyuki Tsutsui, Issei Komuro, Hisao Ogawa, Yoshihiko Saito.
Role of Climatic Factors in the Incidence of Takotsubo Syndrome: A Nationwide Study from 2012 to 2016
ESC Heart Fail. 2020 Jul 27. doi: 10.1002/ehf2.12843.

3. D. Kamon, Y Sugawara, T. Soeda, A. Okamura, Y. Nakada, Y. Hashimoto, T. Ueda, T. Nishida, K. Onoue, S. Okayama, M. Watanabe, R. Kawakami, Y. Saito.
Predominant subtype of heart failure after acute myocardial infarction is heart failure with non-reduced ejection fraction
ESC Heart Failure. 2020

4. Kita Y, Watanabe M, Kamon D, Ueda T, Soeda T, Okayama S, Ishigami K, Kawata H, Horii M, Inoue F, Doi N, Okura H, Uemura S, Saito Y.
Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study.
J Am Heart Assoc. 2020 Aug 18;9(16):e015593.

5. Yoshihiko Saito.
The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection
J Mol Cell Cardiol. 2020

6. Soeda T, Okura H, Saito Y, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Clinical characteristics and in-hospital outcomes in patients aged 80 years or over with cardiac troponin-positive acute myocardial infarction -J-MINUET study.
J Cardiol. 2020 Sep 13:S0914-5087(20)30291-4.

7. Nogi M, Kawakami R, Ishihara S, Hirai K, Nakada Y, Nakagawa H, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Saito Y.
Low Insulin Is an Independent Predictor of All-Cause and Cardiovascular Death in Acute Decompensated Heart Failure Patients Without Diabetes Mellitus.
J Am Heart Assoc. 2020 May 18;9(10)

1. Sadanori Okada, Ken-ichi Samejima, Masaru Matsui, Katsuhiko Morimoto, Riri Furuyama, Kaori Tanabe, Masahiro Eriguchi, Yasuhiro Akai, Yoshihiko Saito, Kazuhiko Tsuruya.
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.
BMJ Open Diabetes Res Care. 2020; 8(2)

2. Yusuke Watanabe, Daiki Seya, Dai Ihara, Shuhei Ishii, Taiki Uemoto, Atsushi Kubo, Yuji Arai, Yoshie Isomoto, Atsushi Nakano, Takaya Abe, Mayo Shigeta, Teruhisa Kawamura, Yoshihiko Saito, Toshihiko Ogura, Osamu Nakagawa.
Importance of endothelial Hey1 expression for thoracic great vessel development and its distal enhancer for Notch-dependent endothelial transcription.
J Biol Chem. 2020 Dec 18; 295(51): 17632–17645.

3. Yoshihiro Hayata, Noriyoshi Sawabata, Takehisa Abe, Tomoaki Hirose, Keigo Yamashita, Shun Hiraga, Ryohei Fukuba, Junichi Takemura, Tomoya Nakano, Yoshihiko Saito, Shigeki Taniguchi.
Improvement in Left Cardiac Function Following Mitral Valve Repair: Analyses Based on Cardiac Magnetic Resonance Imaging.
In Vivo. 2020 Sep-Oct; 34(5): 2897–2903.

4. Hirohiko Motoki, Izuru Masuda, Shinji Yasuno, Koji Oba, Wataru Shoin, Satoru Usami, Yoshihiko Saito, Masako Waki, Mitsuhisa Komatsu, Kenji Ueshima, Yasuaki Nakagawa, Cheol Son, Shin Yonemitsu, Shinya Hiramitsu, Manako Konda, Katsuya Onishi, Koichiro Kuwahara.
Rationale and design of the EMPYREAN study.
ESC Heart Fail. 2020 Oct; 7(5): 3134–3141.

5. Kazunori Omote, Toshiyuki Nagai, Hiroyuki Iwano, Shingo Tsujinaga, Kiwamu Kamiya, Tadao Aikawa, Takao Konishi, Takuma Sato, Yoshiya Kato, Hirokazu Komoriyama, Yuta Kobayashi, Kazuhiro Yamamoto, Tsutomu Yoshikawa, Yoshihiko Saito, Toshihisa Anzai.
Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction.
ESC Heart Fail. 2020 Feb; 7(1): 167–175.

6. Kihei Yoneyama, Koshiro Kanaoka, Satoshi Okayama, Kunihiro Nishimura, Michikazu Nakai, Kunihiro Matsushita, Yoshihiro Miyamoto, Keisuke Kida, Yuki Ishibashi, Masaki Izumo, Makoto Watanabe, Tsunenari Soeda, Hiroyuki Okura, Tomoo Harada, Satoshi Yasuda, Toyoaki Murohara, Hisao Ogawa, Yoshihiko Saito, Yoshihiro J Akashi.
Association between the number of board-certified cardiologists and the risk of in-hospital mortality: a nationwide study involving the Japanese registry of all cardiac and vascular diseases.
BMJ Open. 2019; 9(12): e024657.

7. Araki M, Soeda T*, Kim HO, Thondapu V, Russo M, Kurihara O, Shinohara H, Minami Y, Higuma T, Lee H, Yonetsu T, Kakuta T, Jang IK.
Spatial Distribution of Vulnerable Plaques: Comprehensive In Vivo Coronary Plaque Mapping.
JACC Cardiovasc Imaging. 2020; 13: 1989-1999.

8. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y, McNulty I, Uemura S, Kakuta T, Jang IK.
Predictors of Rapid Plaque Progression: An Optical Coherence Tomography Study.
JACC Cardiovasc Imaging. 2020 [ahead of print]

9. Kurihara O, Takano M, Kakuta T, Soeda T, Crea F, Adriaenssens T, Nef HM, Boeder NF, Yamamoto E, Kim HO, Russo M, McNulty I, Araki M, Nakajima A, Lee H, Mizuno K, Jang IK.
Determinants of ST-segment elevation myocardial infarction as clinical presentation of acute coronary syndrome.
J Thromb Thrombolysis. 2020 [ahead of print]

10. Araki M, Yonetsu T, Kurihara O, Nakajima A, Lee H, Soeda T, Minami Y, Higuma T, Kimura S, Takano M, Yan BP, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Crea F, Kakuta T, Jang IK.
Circadian variations in pathogenesis of ST-segment elevation myocardial infarction: an optical coherence tomography study.
J Thromb Thrombolysis. 2020 [ahead of print]

11. Kurihara O, Takano M, Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Yan BP, Crea F, Higuma T, Kimura S, Minami Y, Adriaenssens T, Boeder NF, Nef HM, Kim CJ, Thondapu V, Kim HO, Russo M, Sugiyama T, Fracassi F, Lee H, Mizuno K, Jang IK.
Seasonal Variations in the Pathogenesis of Acute Coronary Syndromes.
J Am Heart Assoc. 2020; 9: e015579.

12. Kurihara O, Takano M, Soeda T, Fracassi F, Araki M, Nakajima A, McNulty I, Lee H, Mizuno K, Jang IK.
Degree of luminal narrowing and composition of thrombus in plaque erosion.
J Thromb Thrombolysis. 2020 [ahead of print]

13. Kim HO, Kim CJ, Cho JM, Soeda T, Kurihara O, Russo M, Araki M, Lee H, Minami Y, Jang IK.
Characteristics of non-culprit plaques in acute coronary syndrome patients with calcified plaque at the culprit lesion.
Catheter Cardiovasc Interv. 2020 [ahead of print]

14. Russo M, Kim HO, Thondapu V, Kurihara O, Araki M, Shinohara H, Yamamoto E, Lee H, Yonetsu T, Minami Y, Adriaenssens T, Boeder NF, Nef HM, Crea F, Soeda T, Jang IK.
Ethnic Differences in the Pathobiology of Acute Coronary Syndromes Between Asians and Whites.
Am J Cardiol 2020; 125: 1757-1764.

15. Araki M, Yonetsu T, Russo M, Kurihara O, Kim HO, Shinohara H, Thondapu V, Soeda T, Minami Y, Higuma T, Lee H, Kakuta T, Jang IK.
Predictors for layered coronary plaques: an optical coherence tomography study.
J Thromb Thrombolysis. 2020; 50: 886-894.

16. Russo M, Fracassi F, Kurihara O, Kim HO, Thondapu V, Araki M, Shinohara H, Sugiyama T, Yamamoto E, Lee H, Vergallo R, Crea F, Biasucci LM, Yonetsu T, Minami Y, Soeda T, Fuster V, Jang IK.
Healed Plaques in Patients With Stable Angina Pectoris.
Arterioscler Thromb Vasc Biol. 2020; 40: 1587-1597.

17. Nakajima A, Araki M, Kurihara O, Minami Y, Soeda T, Yonetsu T, Crea F, Takano M, Higuma T, Kakuta T, Adriaenssens T, Lee H, Nakamura S, Jang IK.
Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
Catheter Cardiovasc Interv 2020 [Epub ahead of print]

18. Russo M, Kim HO, Kurihara O, Araki M, Shinohara H, Thondapu V, Yonetsu T, Soeda T, Minami Y, Higuma T, Lee H, Fracassi F, Vergallo R, Niccoli G, Crea F, Fuster V, Jang IK.
Characteristics of non-culprit plaques in acute coronary syndrome patients with layered culprit plaque.
Eur Heart J Cardiovasc Imaging. 2020;21:1421-1430.

19. Soejima H, Ogawa H, Morimoto T, Okada S, Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD Trial Investigators.
Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
J Cardiol. 2020 Apr;75(4):387-393.

20. Takahashi N, Ogita M, Suwa S, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Prognostic Impact of B-Type Natriuretic Peptide on Long-Term Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Without Creatine Kinase Elevation.
Int Heart J. 2020 Sep 29;61(5):888-895.

21. Hayata Y, Sawabata N, Abe T, Hirose T, Yamashita K, Hiraga S, Fukuba R, Takemura J, Nakano T, Saito Y, Taniguchi S.
Improvement in Left Cardiac Function Following Mitral Valve Repair: Analyses Based on Cardiac Magnetic Resonance Imaging.
In Vivo. 2020 Sep-Oct;34(5):2897-2903.

22. Toyoda S, Sakuma M, Abe S, Inoue T, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Okamura A, Mano T, Wake M, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Toubaru T, Saku K, Ohshima S, Miyamoto Y, Ogawa H, Ishihara M.
Prediction of Long-Term Outcomes in ST-Elevation Myocardial Infarction and Non-ST Elevation Myocardial Infarction with and without Creatinine Kinase Elevation-Post-Hoc Analysis of the J-MINUET Study.
J Clin Med. 2020 Aug 18;9(8):2667.

23. Motoki H, Masuda I, Yasuno S, Oba K, Shoin W, Usami S, Saito Y, Waki M, Komatsu M, Ueshima K, Nakagawa Y, Son C, Yonemitsu S, Hiramitsu S, Konda M, Onishi K, Kuwahara K.
Rationale and design of the EMPYREAN study.
ESC Heart Fail. 2020 Jun 23;7(5):3134-41.

24. Akahori H, Masuyama T, Imanaka T, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Impact of peripheral artery disease on prognosis after myocardial infarction: The J-MINUET study.
J Cardiol. 2020 Oct;76(4):402-406.

25. Sato R, Sakamoto K, Kaikita K, Tsujita K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Tanabe K, Shibata Y, Owa M, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M.
Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm.
J Clin Med. 2020 Jun 2;9(6):1686.

26. Motoki H, Masuda I, Yasuno S, Oba K, Shoin W, Usami S, Saito Y, Waki M, Komatsu M, Ueshima K, Nakagawa Y, Son C, Yonemitsu S, Hiramitsu S, Konda M, Onishi K, Kuwahara K.
Rationale and design of the EMPYREAN study.
ESC Heart Fail. 2020 Jun 23. doi: 10.1002/ehf2.12825.

27. Matsuzawa Y, Konishi M, Nakai M, Saigusa Y, Taguri M, Gohbara M, Ebina T, Kosuge M, Hibi K, Nishimura K, Miyamoto Y, Yasuda S, Ogawa H, Saito Y, Nakayama N, Takeuchi I, Tamura K, Kimura K.
In-Hospital Mortality in Acute Myocardial Infarction According to Population Density and Primary Angioplasty Procedures Volume.
Circ J. 2020 Jun 25;84(7):1140-1146.

28. Mika Watanabe, Kihei Yoneyama, Michikazu Nakai, Koshiro Kanaoka, Satoshi Okayama, Kunihiro Nishimura, Yoshihiro Miyamoto, Masaki Izumo, Yuki Ishibashi, Takumi Higuma, Tomoo Harada, Satoshi Yasuda, Toyoaki Murohara, Yoshihiko Saito, Yoshihiro J. Akashi
Impact of Board-Certified Cardiologist Characteristics on Risk of In-Hospital Mortality.
Circ Rep 2020; 2: 44–50

29. Konishi M, Matsuzawa Y, Ebina T, Kosuge M, Gohbara M, Nishimura K, Nakai M, Miyamoto Y, Saito Y, Tsutsui H, Komuro I, Ogawa H, Tamura K, Kimura K.
Impact of population density on mortality in patients hospitalized for heart failure - JROAD-DPC Registry Analysis.
J Cardiol. 2020 Apr;75(4):447-453.

30. Kasahara M, Kuwabara Y, Moriyama T, Tanabe K, Satoh-Asahara N, Katsuya T, Hiramitsu S, Shimada H, Sato T, Saito Y, Nakagawa T.
Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial.
Clin Exp Nephrol. 2020 Mar;24(3):235-241.

31. Ishii M, Kaikita K, Sakamoto K, Seki T, Kawakami K, Nakai M, Sumita Y, Nishimura K, Miyamoto Y, Noguchi T, Yasuda S, Tsutsui H, Komuro I, Saito Y, Ogawa H, Tsujita K; JROAD Investigators.
Characteristics and in-hospital mortality of patients with myocardial infarction in the absence of obstructive coronary artery disease in super-aging society.
Int J Cardiol. 2020 Feb 15;301:108-113.

32. Matsumoto C, Ogawa H, Saito Y, Okada S, Soejima H, Sakuma M, Masuda I, Nakayama M, Doi N, Jinnouchi H, Waki M, Morimoto T; JPAD Trial Investigators; JPAD Trial Investigators:.
Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
Diabetes Care. 2020 Feb;43(2):314-320.

33. Oikawa M, Yoshihisa A, Sato Y, Nagai T, Yoshikawa T, Saito Y, Yamamoto K, Takeishi Y, Anzai T.
Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.
Heart Vessels. 2020 Mar 19.

34. Ishii M, Seki T, Kaikita K, Sakamoto K, Nakai M, Sumita Y, Nishimura K, Miyamoto Y, Noguchi T, Yasuda S, Tsutsui H, Komuro I, Saito Y, Ogawa H, Tsujita K, Kawakami K; JROAD Investigators.
Short-term exposure to desert dust and the risk of acute myocardial infarction in Japan: a time-stratified case-crossover study.
Eur J Epidemiol. 2020 Jan 16.

35. Fujino N, Furusho H, Sakata K, Onoue K, Chiang DY, Kiviniemi TO, Buys E, Sips P, Burch ML, Zhao Y, Kelly AE, Namura M, Kita Y, Tsuchiya T, Kaku B, Oe K, Takeda Y, Konno T, Inoue M, Fujita T, Kato T, Funada A, Tada H, Hodatsu A, Nakanishi C, Sakamoto Y, Tsuda T, Nagata Y, Tanaka Y, Okada H, Usuda K, Cui S, Saito Y, MacRae CA, Takashima S, Yamagishi M, Kawashiri MA, Takamura M.
Impact of functional studies on exome sequence variant interpretation in early-onset cardiac conduction system diseases.
Hayashi K, Teramoto R, Nomura A, Asano Y, Beerens M, Kurata Y, Kobayashi I, Cardiovasc Res. 2020 Jan 24.

36. Temma T, Nagai T, Watanabe M, Kamada R, Takahashi Y, Hagiwara H, Koya T, Nakao M, Omote K, Kamiya K, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
Differential Prognostic Impact of Atrial Fibrillation in Hospitalized Heart Failure Patients With Preserved Ejection Fraction According to Coronary Artery Disease Status　- Report From the Japanese Nationwide Multicenter Registry.
Circ J. 2020 Feb 1.

37. Takemura G, Onoue K, Arimoto T, Watanabe T, Tsujimoto A, Takada C, Okada H, Nakano T, Sakaguchi Y, Miyazaki N, Watanabe T, Kanamori H, Ogura S, Saito Y, Fujiwara T, Fujiwara H, Hotta Y.
Vacuolated cardiomyocytes in human endomyocardial biopsy specimens.
J Cardiol Cases. 2019 Oct 7;21(2):54-58.

38. Noguchi T, Yasuda S, Kanaoka K, Terasaki S, Saito Y, Tsutsui H, Komuro I, Ogawa H, Tsujita K, Kawakami K; on the behalf of the JROAD Investigators.
Association of short-term exposure to air pollution with myocardial infarction with and without obstructive coronary artery disease.
Ishii M, Seki T, Kaikita K, Sakamoto K, Nakai M, Sumita Y, Nishimura K, Miyamoto Y, Eur J Prev Cardiol. 2020 Feb 11:

1. Kamon D, Okura H, Okamura A, Nakada Y, Hashimoto Y, Sugawara Y, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
Plasma Renin Activity Is an Independent Prognosticator in Patients With Myocardial Infarction.
Circ J. 2019 Apr 20.

2. Kanaoka K, Okayama S, Nakai M, Sumita Y, Nishimura K, Kawakami R, Okura H, Miyamoto Y, Yasuda S, Tsutsui H, Komuro I, Ogawa H, Saito Y.
Hospitalization Costs for Patients With Acute Congestive Heart Failure in Japan.
Circ J. 2019 Apr 25;83(5):1025-1031.

3. Kanaoka K, Okayama S, Nakai M, Sumita Y, Onoue K, Soeda T, Nishimura K, Kawakami R, Okura H, Miyamoto Y, Yasuda S, Tsutsui H, Komuro I, Ogawa H, Saito Y.
Number of Cardiologists per Cardiovascular Beds and In-Hospital Mortality for Acute Heart Failure: A Nationwide Study in Japan.
J Am Heart Assoc. 2019 Sep 17;8(18):

4. Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano T, Nakagawa H, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y.
Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure.
Circ J. 2019 Jan 25;83(2):395-400.

5. Nakada Y, Kawakami R, Matsushima S, Ide T, Kanaoka K, Ueda T, Ishihara S, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Tsuchihashi-Makaya M, Tsutsui H, Saito Y.
Simple Risk Score to Predict Survival in Acute Decompensated Heart Failure　- A 2 B Score.
Circ J. 2019 Mar 7.

6. Nakada Y, Onoue K, Nakano T, Ishihara S, Kumazawa T, Nakagawa H, Ueda T, Nishida T, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.
Sci Rep. 2019 Oct 30;9(1):15571.

7. Nogi Kazutaka, Shiraishi Atsushi, Yamamoto Ryohei, Sasano Mikio, Matsumoto Takashi, Karumai Toshiyuki, Hayashi Yoshiro.
Intermittent Hemodialysis for Managing Metabolic Acidosis During Resuscitation of Septic Shock: A Descriptive Study.
Critical Care Explorations: December 2019 - Volume 1 - Issue 12.

8. Okura H, Nakada Y, Ishihara S, Nogi M, Onoue K, Soeda T, Okayama S, Watanabe M, Kawakami R, Saito Y.
"Hidden" takotsubo cardiomyopathy in cardiac care unit.
J Echocardiogr. 2019 Dec 13.

9. Onoue K, Takemura G, Nakano T, Miyazaki N, Tsujimoto A, Watanabe T, Okada H, Kanamori H, Sugiura J, Kanaoka K, Ishihara S, Horii M, Akai Y, Sakaguchi Y, Saito Y.
Ultrastructural Evidence of Glycosphingolipid Degradation After Enzyme Replacement Therapy in Patients With Fabry Disease.
Circ J. 2019 Mar 29.

10. Soejima H, Ogawa H, Morimoto T, Okada S, Sakuma M, Nakayama M, Masuda I, Doi N, Uemura S, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators.
One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
J Cardiol. 2019 Jan;73(1):33-37.

11. Takemura G, Onoue K, Nakano T, Nakamura T, Sakaguchi Y, Tsujimoto A, Miyazaki N, Watanabe T, Kanamori H, Okada H, Kawasaki M, Fujiwara T, Fujiwara H, Saito Y.
Possible mechanism for disposal of degenerative cardiomyocytes in human failing hearts: phagocytosis by a neighbour.
ESC Heart Fail. 2019 Feb;6(1):208-216.

12. Ueda T, Kawakami R, Nakada Y, Nakano T, Nakagawa H, Matsui M, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y.
Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
ESC Heart Fail. 2019 Jul 19.

1. Ishii M, Kaikita K, Sakamoto K, Seki T, Kawakami K, Nakai M, Sumita Y, Nishimura K, Miyamoto Y, Noguchi T, Yasuda S, Tsutsui H, Komuro I, Saito Y, Ogawa H, Tsujita K; JROAD Investigators.
Characteristics and in-hospital mortality of patients with myocardial infarction in the absence of obstructive coronary artery disease in super-aging society.
Int J Cardiol. 2019 Oct 25.

2. Kamiya K, Yamamoto T, Tsuchihashi-Makaya M, Ikegame T, Takahashi T, Sato Y, Kotooka N, Saito Y, Tsutsui H, Miyata H, Isobe M.
Nationwide Survey of Multidisciplinary Care and Cardiac Rehabilitation for Patients With Heart Failure in Japan　- An Analysis of the AMED-CHF Study.
Circ J. 2019 Jun 25;83(7):1546-1552.

3. Kasahara M, Kuwabara Y, Moriyama T, Tanabe K, Satoh-Asahara N, Katsuya T, Hiramitsu S, Shimada H, Sato T, Saito Y, Nakagawa T.
Intensive uric acid-lowering therapy in CKD patients: the protocol for a randomized controlled trial.
Clin Exp Nephrol. 2019 Nov 15.

4. Kobayashi Y, Omote K, Nagai T, Kamiya K, Konishi T, Sato T, Kato Y, Komoriyama H, Tsujinaga S, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
Prognostic Value of Serum Uric Acid in Hospitalized Heart Failure Patients With Preserved Ejection Fraction (from the Japanese Nationwide Multicenter Registry).
Am J Cardiol. 2019 Dec 9.

5. Kojima S, Matsui K, Hiramitsu S, Hisatome I, Waki M, Uchiyama K, Yokota N, Tokutake E, Wakasa Y, Jinnouchi H, Kakuda H, Hayashi T, Kawai N, Mori H, Sugawara M, Ohya Y, Kimura K, Saito Y, Ogawa H; Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy (FREED) investigators.
Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy.
Eur Heart J. 2019 Mar 7.

6. Konishi M, Matsuzawa Y, Ebina T, Kosuge M, Gohbara M, Nishimura K, Nakai M, Miyamoto Y, Saito Y, Tsutsui H, Komuro I, Ogawa H, Tamura K, Kimura K.
Impact of population density on mortality in patients hospitalized for heart failure - JROAD-DPC Registry Analysis.
J Cardiol. 2019 Oct 9. pii: S0914-5087(19)30298-9.

7. Marume K, Takashio S, Nagai T, Tsujita K, Saito Y, Yoshikawa T, Anzai T.
Effect of Statins on Mortality in Heart Failure With Preserved Ejection Fraction Without Coronary Artery Disease　- Report From the JASPER Study.
Circ J. 2019 Jan 25;83(2):357-367.

8. Matsumoto C, Ogawa H, Saito Y, Okada S, Soejima H, Sakuma M, Masuda I, Nakayama M, Doi N, Jinnouchi H, Waki M, Morimoto T; JPAD Trial Investigators; JPAD Trial Investigators.
Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
Diabetes Care. 2019 Dec 4.

9. Nakao K, Yasuda S, Nishimura K, Noguchi T, Nakai M, Miyamoto Y, Sumita Y, Shishido T, Anzai T, Ito H, Tsutsui H, Saito Y, Komuro I, Ogawa H.
Prescription Rates of Guideline-Directed Medications Are Associated With In-Hospital Mortality Among Japanese Patients With Acute Myocardial Infarction: A Report From JROAD - DPC Study.
J Am Heart Assoc. 2019 Apr 2;8(7):

10. Ogata S, Nishimura K, Guzman-Castillo M, Sumita Y, Nakai M, Nakao YM, Nishi N, Noguchi T, Sekikawa A, Saito Y, Watanabe T, Kobayashi Y, Okamura T, Ogawa H, Yasuda S, Miyamoto Y, Capewell S, O'Flaherty M.
Explaining the decline in coronary heart disease mortality rates in Japan: Contributions of changes in risk factors and evidence-based treatments between 1980 and 2012.
Int J Cardiol. 2019 Feb 14. pii: S0167-5273(18)34148-2.

11. Okuno K, Naito Y, Asakura M, Sugahara M, Ando T, Yasumura S, Nagai T, Saito Y, Yoshikawa T, Masuyama T, Anzai T.
Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
Heart Vessels. 2019 Jan 24.

12. Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET Investigators.
Admission Heart Rate Is a Determinant of Effectiveness of Beta-Blockers in Acute Myocardial Infarction Patients.
Circ J. 2019 Apr 25;83(5):1054-1063.

13. Okuno T, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Mano T, Hirata K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Tobaru T, Saku K, Ohshima S, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Association of onset-season with characteristics and long-term outcomes in acute myocardial infarction patients: results from the Japanese registry of acute myocardial infarction diagnosed by universal definition (J-MINUET) substudy.
Heart Vessels. 2019 May 25.

14. Omote K, Nagai T, Iwano H, Tsujinaga S, Kamiya K, Aikawa T, Konishi T, Sato T, Kato Y, Komoriyama H, Kobayashi Y, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
Left ventricular outflow tract velocity time integral in hospitalized heart failure with preserved ejection fraction.
ESC Heart Fail. 2019 Dec 18.

15. Omote K, Nagai T, Kamiya K, Aikawa T, Tsujinaga S, Kato Y, Komoriyama H, Iwano H, Yamamoto K, Yoshikawa T, Saito Y, Anzai T.
Long-term Prognostic Significance of Admission Tricuspid Regurgitation Pressure Gradient in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction: A Report From the Japanese Real-World Multicenter Registry.
J Card Fail. 2019 Jul 22.

16. Sato Y, Yoshihisa A, Oikawa M, Nagai T, Yoshikawa T, Saito Y, Yamamoto K, Takeishi Y, Anzai T.
Hyponatremia at discharge is associated with adverse prognosis in acute heart failure syndromes with preserved ejection fraction: a report from the JASPER registry.
Eur Heart J Acute Cardiovasc Care. 2019 Jan 22.

17. Sato Y, Yoshihisa A, Oikawa M, Nagai T, Yoshikawa T, Saito Y, Yamamoto K, Takeishi Y, Anzai T.
Prognostic impact of worsening renal function in hospitalized heart failure patients with preserved ejection fraction -A report from the JASPER Registry.
J Card Fail. 2019 Apr 17.

18. Sato Y, Yoshihisa A, Oikawa M, Nagai T, Yoshikawa T, Saito Y, Yamamoto K, Takeishi Y, Anzai T.
Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.
Int Heart J. 2019 Jun 28.

19. Soejima H, Ogawa H, Morimoto T, Okada S, Matsumoto C, Nakayama M, Masuda I, Jinnouchi H, Waki M, Saito Y; JPAD Trial Investigators.
Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
J Cardiol. 2019 Sep 26. pii: S0914-5087(19)30283-7.

20. Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Crea F, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fujimoto JG, Fuster V, Finn AV, Falk E, Jang IK.
Calcified Plaques in Patients With Acute Coronary Syndromes.
JACC Cardiovasc Interv. 2019 Mar 25;12(6):531-540.

21. Tsutsui H, Momomura SI, Masuyama T, Saito Y, Komuro I, Murohara T, Kinugawa S; CIBIS-J Investigators.
Tolerability, Efficacy, and Safety of Bisoprolol vs. Carvedilol in Japanese Patients With Heart Failure and Reduced Ejection Fraction　- The CIBIS-J Trial.
Circ J. 2019 Apr 6.

22. Tsutsui H, Momomura SI, Yamashina A, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Yano M, Yamamoto K, Ako J, Inomata T, Sakata Y, Tanaka T, Kawasaki Y; J-SHIFT Study Investigators.
Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure　- J-SHIFT Study.
Circ J. 2019 Aug 8.

23. Uemura S, Okamoto H, Nakai M, Nishimura K, Miyamoto Y, Yasuda S, Tanaka N, Kohsaka S, Kadota K, Saito Y, Tsutsui H, Komuro I, Ikari Y, Ogawa H, Nakamura M.
Primary Percutaneous Coronary Intervention in Elderly Patients With Acute Myocardial Infarction　- An Analysis From a Japanese Nationwide Claim-Based Database.
Circ J. 2019 May 24;83(6):1229-1238.

24. Yamamoto E, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fracassi F, Sugiyama T, Lee H, Crea F, Kimura T, Fujimoto JG, Fuster V, Jang IK.
Clinical and Laboratory Predictors for Plaque Erosion in Patients With Acute Coronary Syndromes.
J Am Heart Assoc. 2019 Nov 5;8(21):e012322.

25. Yoneyama K, Kanaoka K, Okayama S, Nishimura K, Nakai M, Matsushita K, Miyamoto Y, Kida K, Ishibashi Y, Izumo M, Watanabe M, Soeda T, Okura H, Harada T, Yasuda S, Murohara T, Ogawa H, Saito Y, Akashi YJ.
Association between the number of board-certified cardiologists and the risk of in-hospital mortality: a nationwide study involving the Japanese registry of all cardiac and vascular diseases.
BMJ Open. 2019 Dec 15;9(12).

1. Goryo Y, Kume T, Ueda T, Watanabe M, Yamada R, Neishi Y, Saito Y, Uemura S.
Vascular Healing Response after Everolimus-Eluting Stent Implantation in Acute Coronary Syndrome Culprit Lesions: Comparison with Implantation in Stable Angina Pectoris.
Acta Cardiol Sin. 2018 Mar;34(2):124-129.

2. Ishihara S, Kioka H, Ohtani T, Asano Y, Yamaguchi O, Hikoso S, Toda K, Saito Y, Sawa Y, Yamauchi-Takihara K, Sakata Y.
Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
Pulm Circ. 2018 Jul-Sep;8(3)

3. Kanaoka K, Horii M, Nagato H, Kaneda K.
A giant pulmonary artery aneurysm.
Eur Heart J Cardiovasc Imaging. 2018 Feb 1;19(2):236.

4. Kanaoka K, Mori H, Fumimoto A.
Concern About the Association Between Salivary Cortisol and Subsequent Anxiety Among Family Members of ICU Patients.
Crit Care Med. 2018 Jun;46(6):e624.

5. Kanaoka K, Nishida T.
Successful pulmonary vein isolation by ablation in the right atrium.
J Cardiovasc Electrophysiol. 2018 Mar;29(3):483-484.

6. Kanaoka K, Okayama S, Yoneyama K, Nakai M, Nishimura K, Kawata H, Horii M, Kawakami R, Okura H, Miyamoto Y, Akashi Y, Saito Y.
Number of Board-Certified Cardiologists and Acute Myocardial Infarction-Related Mortality in Japan　- JROAD and JROAD-DPC Registry Analysis.
Circ J. 2018 Sep 12

7. Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano T, Nakagawa H, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Okura H, Saito Y.
Value of Placental Growth Factor as a Predictor of Adverse Events During the Acute Phase of Acute Decompensated Heart Failure.
Circ J. 2018 Dec 26.

8. Nakano T, Onoue K, Nakada Y, Nakagawa H, Kumazawa T, Ueda T, Nishida T, Soeda T, Okayama S, Watanabe M, Kawata H, Kawakami R, Horii M, Okura H, Uemura S, Hatakeyama K, Sakaguchi Y, Saito Y.
Alteration of β-Adrenoceptor Signaling in Left Ventricle of Acute Phase Takotsubo Syndrome: a Human Study.
Sci Rep. 2018 Aug 24;8(1):12731.

9. Nishimoto M, Matsui M, Tsushima H, Tanabe K, Tagawa M, Samejima KI, Akai Y, Saito Y.
Acute kidney injury in a postpartum woman with paroxysmal nocturnal hemoglobinuria: A case report and literature review.
Hemodial Int. 2018 Jan;22(1):

10. Okada S, Morimoto T, Ogawa H, Sakuma M, Matsumoto C, Soejima H, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Saito Y; JPAD Trial Investigators.
Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
Diabetes Care. 2018 Aug;41(8):1757-1764.

11. Okura H, Saito Y, Soeda T, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET investigators.
Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction:results from J-MINUET.
Heart Vessels. 2018 Nov 2

12. Onishi R, Kanaoka K, Sugiura J, Tokunaga M, Takemoto Y, Onoue K, Yamamoto Y, Horii M, Saito Y.
A Cardiac Variant of Fabry Disease Diagnosed with Chance Urinary Mulberry Cells.
Intern Med. 2018 Jul 6 .1177-18

13. Onoue K, Saito Y.
Hepatitis C Virus and Cardiovascular Disease.
Circ J. 2018 May 8

14. Sakagami A, Okura H, Uemura T, Saito Y.
Inter-atrial Septal Thrombus without PFO.
Intern Med. 2018 Feb 1;57(3):445.

15. Soejima H, Ogawa H, Morimoto T, Okada S, Sakuma M, Nakayama M, Masuda I, Doi N, Uemura S, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators.
One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
J Cardiol. 2019 Jan;73(1):33-37.

16. Sugawara Y, Ueda T, Soeda T, Watanabe M, Okura H, Saito Y.
Plaque modification of severely calcified coronary lesions by scoring balloon angioplasty using Lacrosse non-slip element: insights from an optical coherence tomography evaluation.
Cardiovasc Interv Ther. 2018 Oct 19.

17. Sugiura J, Watanabe M, Toyokawa N, Kamon D, Isojima T, Ueda T, Soeda T, Okura H, Saito Y.
Progression of a Calcified Nodule Causing Acute Myocardial Infarction in a Patient on Hemodialysis　- Serial Optical Coherence Tomography.
Circ J. 2018 Aug 24.

18. Tagawa M, Hamano T, Sueta S, Ogata S, Saito Y.
Author Correction: Higher dialysate calcium concentration is associated with incident myocardial infarction among diabetic patients with low bone turnover: a longitudinal study.
Sci Rep. 2018 Aug 30;8(1):13217.

19. Tagawa M, Hamano T, Sueta S, Ogata S, Saito Y.
Higher dialysate calcium concentration is associated with incident myocardial infarction among diabetic patients with low bone turnover: a longitudinal study.
Sci Rep. 2018 Jul 3;8(1):10060.

20. Takemura G, Onoue K, Nakano T, Nakamura T, Sakaguchi Y, Tsujimoto A, Miyazaki N, Watanabe T, Kanamori H, Okada H, Kawasaki M, Fujiwara T, Fujiwara H, Saito Y.
Possible mechanism for disposal of degenerative cardiomyocytes in human failing hearts: phagocytosis by a neighbour.
ESC Heart Fail. 2018 Nov 27.

21. Toyokawa N, Okura H, Saito Y.
From Mitral Annular Calcification to Calcified Amorphous Tumor.
Intern Med. 2018 Feb 1;57(3):443.

22. Watanabe, M, Okura, H, Okamura, A. Iwai, A, Keshi, A, Kamon, D, Isojima, T, Ueda, T, Soeda, T. Saito, Y.
Usefulness of longitudinal reconstructed optical coherence tomography images for predicting the need for the reverse wire technique during coronary bifurcation interventions.
Catheterization and Cardiovascular Interventions. 2018 Nov 25.

1. Araki M, Hisamitsu T, Kinugasa-Katayama Y, Tanaka T, Harada Y, Nakao S, Hanada S, Ishii S, Fujita M, Kawamura T, Saito Y, Nishiyama K, Watanabe Y, Nakagawa O.
Serum/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells.
Angiogenesis. 2018 May;21(2):415-423.

2. Hashimoto T, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Ohshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy.
Heart Vessels. 2018 May;33(5):481-488

3. Hashimoto T, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
Pre-Procedural Thrombolysis in Myocardial Infarction Flow in Patients with ST-Segment Elevation Myocardial Infarction.
Int Heart J. 2018 Aug 29.

4. Horiuchi Y, Aoki J, Tanabe K, Nakao K, Ozaki Y, Kimura K, Ako J, Yasuda S, Noguchi T, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Shibata Y, Nakai M, Nishimura K, Miyamoto Y,
A High Level of Blood Urea Nitrogen Is a Significant Predictor for In-hospital Mortality in Patients with Acute Myocardial Infarction.
Ishihara M; J-MINUET investigators.
Int Heart J. 2018 Mar 30;59(2):263-271.

5. Itoh H, Komuro I, Takeuchi M, Akasaka T, Daida H, Egashira Y, Fujita H, Higaki J, Hirata KI, Ishibashi S, Isshiki T, Ito S, Kashiwagi A, Kato S, Kitagawa K, Kitakaze M, Kitazono T, Kurabayashi M, Miyauchi K, Murakami T, Murohara T, Node K, Ogawa S, Saito Y, Seino Y, Shigeeda T, Shindo S, Sugawara M, Sugiyama S, Terauchi Y, Tsutsui H, Ueshima K, Utsunomiya K, Yamagishi M, Yamazaki T, Yo S, Yokote K, Yoshida K, Yoshimura M, Yoshimura N, Nakao K, Nagai R; EMPATHY Investigators.
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study.
Diabetes Care. 2018 Apr 6

6. Nagai T, Yoshikawa T, Saito Y, Takeishi Y, Yamamoto K, Ogawa H, Anzai T; JASPER Investigators.
Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction - A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry.
Circ J. 2018 Mar 23

7. Nakajima K, Aiba T, Makiyama T, Nishiuchi S, Ohno S, Kato K, Yamamoto Y, Doi T, Shizuta S, Onoue K, Yagihara N, Ishikawa T, Watanabe I, Kawakami H, Oginosawa Y, Murakoshi N, Nogami A, Aonuma K, Saito Y, Kimura T, Yasuda S, Makita N, Shimizu W, Horie M, Kusano K.
Clinical Manifestations and Long-Term Mortality in Lamin A/C Mutation Carriers From a Japanese Multicenter Registry.
Circ J. 2018 Aug 4.

8. Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A, Goncalvesova E, Janssens S, Katova T, Køber L, Lelonek M, Linssen G, Lund LH, O'Meara E, Merkely B, Milicic D, Oh BH, Perrone SV, Ranjith N, Saito Y, Saraiva JF, Shah S, Seferovic PM, Senni M, Sibulo AS Jr, Sim D, Sweitzer NK, Taurio J, Vinereanu D, Vrtovec B, Widimský J Jr, Yilmaz MB, Zhou J, Zweiker R, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Pieske B, Redfield MM, Rouleau JL, Van Veldhuisen DJ, Zannad F, Zile MR, McMurray JJV.
Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial.
Circ Heart Fail. 2018 Jul;11(7) :e004962

9. Takami T, Okada S, Saito Y, Nishijima Y, Kobori H, Nishiyama A.
Effects of Olmesartan and Azilsartan on Albuminuria and the Intrarenal Renin-Angiotensin System.
World J Res Rev. 2018 Jan;6(1):7-10.

10. Tauscher S, Nakagawa H, Völker K, Werner F, Krebes L, Potapenko T, Doose S, Birkenfeld AL, Baba HA, Kuhn M.
β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Cardiovasc Diabetol. 2018 Jul 17;17(1):103

11. Tobita T, Nomura S, Fujita T, Morita H, Asano Y, Onoue K, Ito M, Imai Y, Suzuki A, Ko T, Satoh M, Fujita K, Naito AT, Furutani Y, Toko H, Harada M, Amiya E, Hatano M, Takimoto E, Shiga T, Nakanishi T, Sakata Y, Ono M, Saito Y, Takashima S, Hagiwara N, Aburatani H, Komuro I.
Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular reverse remodeling.
Sci Rep. 2018 Jan 31;8(1)

12. Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Ohishi T, Okino N, Kitamura T, Guo W.
Angiotensin Receptor Neprilysin Inhibitor in Japanese Patients With Heart Failure and Reduced Ejection Fraction　- Baseline Characteristics and Treatment of PARALLEL-HF Trial.
Circ J. 2018 Jul 26. CJ-17-1424. [Epub ahead of print]

1. Matsui M, Akai Y, Samejima KI, Tsushima H, Tanabe K, Morimoto K, Tagawa M, Saito Y.
Prognostic Value of Predialysis Indices for Technique Failure and Mortality in Peritoneal Dialysis Patients.
Ther Apher Dial. 2017 Oct;21(5):493-499. doi: 10.1111/1744-9987.12546. Epub 2017 May 15.

2. Toyokawa N, Okura H, Saito Y.
From Mitral Annular Calcification to Calcified Amorphous Tumor.
Intern Med. 2017 Nov 1. doi: 10.2169/internalmedicine.9310-17

3. Sakagami A, Okura H, Uemura T, Saito Y.
Inter-atrial Septal Thrombus without PFO.
Intern Med. 2017 Oct 16. doi: 10.2169/internalmedicine.9308-17. [Epub ahead of print]

4. Nishimoto M, Matsui M, Tsushima H, Tanabe K, Tagawa M, Samejima KI, Akai Y, Saito Y.
Acute kidney injury in a postpartum woman with paroxysmal nocturnal hemoglobinuria: A case report and literature review.
Hemodial Int. 2017 Aug 10. doi: 10.1111/hdi.12591. [Epub ahead of print]

5. Nogi M, Okura H, Sakagami A, Tamaki H, Saito Y.
Progressive mitral regurgitation in a patient with tropical endomyocardial fibrosis.
Eur Heart J Cardiovasc Imaging. 18:1071, 2017

6. Soeda T.
The mechanism of microvascular obstruction in patients with acute ST-segment elevation myocardial infarction: new light from optical coherence tomography.
Coron Artery Dis. 28:188-189, 2017

7. Nakada Y, Kawakami R, Matsui M, Ueda T, Nakano T, Takitsume A, Nakagawa N, Nishida T, Onoue K, Soeda T, Okayama S, Watanabe M, Kawata H, Okura H, Saito Y.
Prognostic Value of Urinary Neutrophil Gelatinase-Associated Lipocalin on the First Day of Admission for Adverse Events in Patients with Acute Decompensated Heart Failure.
J Am Heart Assoc. 2017 May 18;6(5). pii: e004582.

8. Morimoto K, Akai Y, Matsui M, Yano H, Tagawa M, Samejima K, Saito Y.
Acute pulmonary thromboembolism occurring during treatment with tolvaptan in a patient with autosomal-dominant polycystic kidney disease.
CEN Case Reports. 6:61-65, 2017.

9. Saito Y, Ogawa H, Morimoto T.
Response by Saito et al to Letter Regarding Article, "Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial".
Circulation. 135:e1010-e1011, 2017.

10. Tagawa M, Ghosn M, Wachtel H, Fraker D, Townsend RR, Trerotola S, Cohen DL.
Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism.
J Hum Hypertens. 31:444-449, 2017

11. Saito Y, Okada S, Ogawa H, Soejima H, Sakuma M, Nakayama M, Doi N, Jinnouchi H, Waki M, Masuda I, Morimoto T; JPAD Trial Investigators.
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes: 10-year Follow-up of a Randomized Controlled Trial.
Circulation. 135:659-670, 2017.

12. Kojima S, Matsui K, Ogawa H, Jinnouchi H, Hiramitsu S, Hayashi T, Yokota N, Kawai N, Tokutake E, Uchiyama K, Sugawara M, Kakuda H, Wakasa Y, Mori H, Hisatome I, Waki M, Ohya Y, Kimura K, Saito Y; Febuxostat for Cerebral and Cardiorenovascular Events Prevention Study (FREED) investigators.
Rationale, design, and baseline characteristics of a study to evaluate the effect of febuxostat in preventing cerebral, cardiovascular, and renal events in patients with hyperuricemia.
J Cardiol. 69:169-175, 2017.

1. Nishiuchi S, Makiyama T, Aiba T, Nakajima K, Hirose S, Kohjitani H, Yamamoto Y, Harita T, Hayano M, Wuriyanghai Y, Chen J, Sasaki K, Yagihara N, Ishikawa T, Onoue K, Murakoshi N, Watanabe I, Ohkubo K, Watanabe H, Ohno S, Doi T, Shizuta S, Minamino T, Saito Y, Oginosawa Y, Nogami A, Aonuma K, Kusano K, Makita N, Shimizu W, Horie M, Kimura T.
Gene-Based Risk Stratification for Cardiac Disorders in Mutation Carriers.
Circ Cardiovasc Genet. 2017 Dec;10(6). doi: 10.1161/CIRCGENETICS.116.001603.

2. Masuda H, Kobayashi T, Hachiya A, Nakashima Y, Shimizu H, Nozawa T, Ogihara Y, Ito S, Takatsuki S, Katsumata N, Suzuki Y, Takenaka S, Hirono K, Kobayashi T, Suzuki H, Suganuma E, Takahashi K, Saji T; Committee of Survey on Infliximab use for Kawasaki disease.
Infliximab for the Treatmen of Refractory Kawasaki Disease: A Nationwide Survey in Japan.
J Pediatr. 2017 Dec 7. doi: 10.1016/j.jpeds.2017.10.013. [Epub ahead of print]

3. Kakizaki Y, Makino N, Ando Y, Matsuda A, Ishizawa T, Saito Y, Suto A, Yamakawa M, Kimura W, Ueno Y.
A case of pancreatic intraepithelial neoplasia-3 with autoimmune pancreatitis.
Nihon Shokakibyo Gakkai Zasshi. 2017;114(6):1023-1030. doi: 10.11405/nisshoshi.114.1023. Japanese.

4. Ito M, Makino N, Matsuda A, Ikeda Y, Kakizaki Y, Saito Y, Ueno Y, Kawata S.
High Glucose Accelerates Cell Proliferation and Increases the Secretion and mRNA Expression of Osteopontin in Human Pancreatic Duct Epithelial Cells.
Int J Mol Sci. 2017 Apr 12;18(4). 10.3390/ijms18040807.

5. Ishihara M, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Fujino M, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Tobaru T, Oshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H; J-MINUET Investigators.
Long-Term Outcomes of Non-ST-Elevation Myocardial Infarction Without Creatine Kinase Elevation The J-MINUET Study.
Circ J. 2017 Jun 23;81(7):958-965. doi: 10.1253/circj.CJ-17-0033. Epub 2017 Mar 17.

6. Kuji S, Kosuge M, Kimura K, Nakao K, Ozaki Y, Ako J, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET Investigators.
Impact of Acute Kidney Injury on In-Hospital Outcomes of Patients With Acute Myocardial Infarction Results From the Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) Substudy.
Circ J. 2017 Apr 25;81(5):733-739. doi: 10.1253/circj.CJ-16-1094. Epub 2017 Feb 9.

7. Minami Y, Wang Z, Aguirre AD, Ong DS, Kim CJ, Uemura S, Soeda T, Lee H, Fujimoto J, Jang IK.
Clinical Predictors for Lack of Favorable Vascular Response to Statin Therapy in Patients With Coronary Artery Disease: A Serial Optical Coherence Tomography Study.
J Am Heart Assoc. 2017 Nov 1;6(11). pii: e006241.

8. Bryniarski KL, Walters DL, Kim CJ, Soeda T, Higuma T, Yamamoto E, Xing L, Sugiyama T, Zanchin T, Bryniarski L, Dudek D, Lee H, Jang IK.
SYNTAX Score and Pre- and Poststent Optical Coherence Tomography Findings in the Left Anterior Descending Coronary Artery in Patients With Stable Angina Pectoris.
Am J Cardiol. 120:898-903, 2017.

9. Hirai N, Kasahara K, Uno K, Ogawa Y, Ogawa T, Yonekawa S, Nakano R, Yano H, Sakagami A, Uemura T, Okura H, Saito Y, Yoshikawa M, Mikasa K.
Infective Endocarditis Complicated by Intraventricular Abscesses, Pericarditis, and Mycotic Aneurysm Due to an Emerging Strain of Serotype VI Streptococcus agalactiae.
Jpn J Infect Dis. 70:685-686, 2017

10. Fujikura H, Kasahara K, Ogawa Y, Hirai N, Yoshii S, Yoshihara S, Ogawa T, Yonekawa S, Imakita N, Nishioka Y, Yoneda T, Yoshida K, Samejima KI, Tanabe K, Saito Y, Yano H, Mikasa K.
Mycobacterium wolinskyi Peritonitis after Peritoneal Catheter Embedment Surgery.
Intern Med.56:3097-3101, 2017

11. Hashimoto T, Ako J, Nakao K, Ozaki Y, Kimura K, Noguchi T, Yasuda S, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Tsujita K, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Ohshima S, Nakai M, Nishimura K, Miyamoto Y, Ogawa H, Ishihara M; J-MINUET investigators.
A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: a J-MINUET substudy.
Heart Vessels. 2017 Nov 16. doi: 10.1007/s00380-017-1084-2. [Epub ahead of print]

12. Takahashi N, Saeki T, Komatsuda A, Munemura C, Fukui T, Imai N, Homma N, Hatta T, Samejima KI, Fujimoto T, Omori H, Ito Y, Nishikawa Y, Kobayashi M, Morikawa Y, Fukushima S, Yokoi S, Mikami D, Kasuno K, Kimura H, Nemoto T, Nakamoto Y, Sada K, Sugai M, Naiki H, Yoshida H, Narita I, Saito Y, Iwano M.
Tubulointerstitial Nephritis with IgM-Positive Plasma Cells.
J Am Soc Nephrol. 2017 Aug 9. pii: ASN.2016101074. doi: 10.1681/ASN.2016101074. [Epub ahead of print]

13. Ogita M, Suwa S, Ebina H, Nakao K, Ozaki Y, Kimura K, Ako J, Noguchi T, Yasuda S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Hirata K, Tanabe K, Shibata Y, Owa M, Hokimoto S, Funayama H, Kokubu N, Kozuma K, Uemura S, Toubaru T, Saku K, Oshima S, Nishimura K, Miyamoto Y, Ishihara M; J-MINUET investigators.
Off-hours presentation does not affect in-hospital mortality of Japanese patients with acute myocardial infarction: J-MINUET substudy.
J Cardiol. 2017 Jul 3. pii: S0914-5087(17)30158-2. doi: 10.1016/j.jjcc.2017.05.006. [Epub ahead of print]

14. Momomura SI, Saito Y, Yasumura Y, Yamamoto K, Sakata Y, Daimon M, Kinugawa K, Okamoto H, Dohi N, Komuro I.
Efficacy and Safety of Switching From Oral Bisoprolol to Transdermal Patch in Japanese Patients With Chronic Heart Failure.
Circ J. 2017 Aug 2. doi: 10.1253/circj.CJ-17-0532. [Epub ahead of print]

15. Kobayashi Y, Okura H, Kobayashi Y, Fukuda S, Hirohata A, Yoshida K.
Left ventricular myocardial function assessed by three-dimensional speckle tracking echocardiography in Takotsubo cardiomyopathy.
Echocardiography. 34:523-529, 2017.

16. Hu S, Zhu Y, Zhang Y, Dai J, Li L, Dauerman H, Soeda T, Wang Z, Lee H, Wang C, Zhe C, Wang Y, Zheng G, Zhang S, Jia H, Yu B, Jang IK.
Management and Outcome of Patients With Acute Coronary Syndrome Caused by Plaque Rupture Versus Plaque Erosion: An Intravascular Optical Coherence Tomography Study.
J Am Heart Assoc. 2017 Feb 24;6(3). pii: e004730.

17. Tsutsui H, Momomura S, Saito Y, Ito H, Yamamoto K, Ohishi T, Okino N, Guo W.
Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study.
J Cardiol. 70:225-231, 2017.

18. Kume T, Okura H, Yamada R, Koyama T, Fukuhara K, Goryo Y, Kamata Y, Okamoto H, Tamada T, Imai K, Neishi Y, Uemura S.
In vivo assessment of vasa vasorum neovascularization using intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
J Cardiol. 69:601-605, 2017

19. Dai J, Hou J, Xing L, Jia H, Hu S, Soeda T, Minami Y, Ong D, Vergallo R, Zhang S, Lee H, Yu B, Jang IK.
Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
Coron Artery Dis. 28:209-217, 2017

20. Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, Toyoaki M, Ogawa H, Akasaka T, Yoshimura M, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, Saito Y; CINC-J study investigators.
Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
Int J Cardiol. 227: 424-429, 2017.

21. Kobayashi Y, Okura H, Neishi Y, Higa T, Kobayashi Y, Uemura S, Yoshida K.
Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis.
Coron Artery Dis. 28:104-109, 2017

1. Matsui M, Samejima K, Takeda Y, Morimoto K, Tagawa M, Onoue K, Okayama S, Kawata H, Kawakami R, Akai Y, Okura H, Saito Y.
Angiogenic Factors and Risks of Technique Failure and Cardiovascular Events in Patients Receiving Peritoneal Dialysis.
Cardiorenal Med. 6: 251-259, 2016.

2. Nakada Y, Kawakami R, Nakano T, Takitsume A, Nakagawa H, Ueda T, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe Y, Kawata H, Okura H, Saito Y.
Gender Differences in Clinical Characteristics and Long-Term Outcome in Acute Decompensated Heart Failure Patients with Preserved and Reduced Ejection Fraction
Am J Physiol Heart Circ Physiol. 310:H813-820, 2016

3. Nakagawa H, Mizuno Y, Harada E, Morikawa Y, Kuwahara K, Saito Y, Yasue H.
Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension.
Am J Med Sci. 352:534-539, 2016.

4. Nakagawa H, Somekawa S, Onoue K, Kumazawa T, Ueda T, Seno A, Nakada Y, Nakano T, Matsui M, Soeda T, Okayama S, Kawakami R, Kawata H, Okura H, Saito Y.
Salt accelerates aldosterone-induced cardiac remodeling in the absence of guanylyl cyclase-A signaling.
Life Sci. 165:9-15, 2016.

5. Okada S, Morimoto T, Ogawa H, Sakuma M, Soejima H, Nakayama M, Jinnouchi H, Waki M, Akai Y, Ishii H, Saito Y; investigators for the Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes (JPAD) trial.
Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
PLoS One. 11;e0147635, 2016.

6. Seno A, Takeda Y, Matsui M, Okuda A, Nakano T, Yasuki N, Kumasawa T, Hitoshi N, Nishida T, Onoue K, Somekawa S, Watanabe M, Kawata H, Kawakami R, Okura H, Uemura S, Saito Y.
Suppressed Production of Soluble Fms-like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure
Hypertension. 68: 678-87, 2016.

7. Soeda T, Higuma T, Abe N, Yamada M, Yokoyama H, Shibutani S, Ong DS, Vergallo R, Minami Y, Lee H, Okumura K, Jang IK.
Morphological predictors for no reflow phenomenon after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction caused by plaque rupture.
Eur Heart J Cardiovasc Imaging. 27:435-6, 2016.

8. Soeda T, Uemura S, Watanabe M, Ishihara S, Ueda T, Sugawara Y, Okura H, Saito Y.
Multifocal coronary thrombosis on nondisrupted plaque: observation with optical coherence tomography.
Coron Artery Dis. 27:435-436, 2016.

9. Takemura G, Onoue K, Kashimura T, Kanamori H, Okada H, Tsujimoto A, Miyazaki N, Nakano T, Sakaguchi Y, Saito Y.
Electron Microscopic Findings Are an Important Aid for Diagnosing Mitochondrial Cardiomyopathy With Mitochondrial DNA Mutation 3243A>G.
Circ Heart Fail. 2016 Jul;9(7). pii: e003283.

10. Ueda T, Uemura S, Watanabe M, Dote Y, Goryo Y, Sugawara Y, Soeda T, Okayama S, Kawata H, Kawakami R, Okura H, Saito Y.
Thin-cap fibroatheroma and large calcification at the proximal stent edge correlate with a high proportion of uncovered stent struts in the chronic phase.
Coron Artery Dis. 27:376-84, 2016

11. Watanabe M, Uemura S, Kita Y, Sugawara Y, Goryo Y, Ueda T, Soeda T, Okayama S, Okura H, Kume T, Saito Y.
Impact of branching angle on neointimal coverage of drug-eluting stents implanted in bifurcation lesions
Coron Artery Dis. 27:682-689, 2016

1. Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, Toyoaki M, Ogawa H, Akasaka T, Yoshimura M, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, Saito Y; CINC-J study investigators.
Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
Int J Cardiol. 2017 Jan 15;227:424-429. doi: 10.1016/j.ijcard.2016.11.019. Epub 2016 Nov 7.

2. Tsutsui H, Momomura S, Yamashina A, Ogawa H, Shimokawa H, Kihara Y, Saito Y, Hagiwara N, Ito H, Ako J, Inomata T, Tanaka T, Kawasaki Y; study investigators.
Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure A Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Circ J. 2016;80(3):668-76. doi: 10.1253/circj.CJ-15-1112. Epub 2016 Jan 14.

3. Sakamoto T, Ogawa H, Nakao K, Hokimoto S, Tsujita K, Koide S, Yamamoto N, Shimomura H, Matsumura T, Oshima S, Kikuta K, Oka H, Kimura K, Matsui K; 4C (Candesartan for Prevention of Cardiovascular Events after CYPHER? or TAXUS? Coronary Stenting) study investigators.
Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The
J Cardiol. 2016 Apr;67(4):371-7. doi: 10.1016/j.jjcc.2015.06.009. Epub 2015 Aug 4.

4. Bryniarski KL, Tahk SJ, Choi SY, Soeda T, Higuma T, Yamamoto E, Xing L, Dai J, Zanchin T, Lee H, Jang IK.
Clinical, Angiographic, IVUS, and OCT predictors for Irregular Protrusion after coronary stenting.
EuroIntervention. 2016 Dec 20. pii: EIJ-D-16-00679. doi: 10.4244/EIJ-D-16-00679. [Epub ahead of print]

5. Fujino M, Ishihara M, Ogawa H, Nakao K, Yasuda S, Noguchi T, Ozaki Y, Kimura K, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Hirohata A, Morita Y, Inoue T, Okamura A, Uematsu M, Ako J, Nakai M, Nishimura K, Miyamoto Y; J-MINUET Investigators.
Impact of symptom presentation on in-hospital outcomes in patients with acute myocardial infarction.
J Cardiol. 2016 Nov 14. pii: S0914-5087(16)30240-4.

6. Fukuhara K, Okura H, Kume T, Yamada R, Neishi Y, Uemura S.
In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.
J Cardiol. 67:437-41, 2016

7. Gao L, Lee S, Kim CJ, Minami Y, Ong DS, Soeda T, Lowe H, Choi SY, Lerman A, Lee J, Lee H, Uemura S, Yu B, Jang IK.
Incidence and Morphological Predictors of Intrastent Coronary Thrombus After Drug-Eluting Stent Implantation (from a Multicenter Registry).
Am J Cardiol. 117:369-75, 2016

8. Gin AL, Vergallo R, Minami Y, Ong DS, Hou J, Jia H, Soeda T, Hu S, Zhang S, Lee H, Yu B, Jang IK.
Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.
Coron Artery Dis. 2016 Jul 27. [Epub ahead of print]

9. Gin AL, Vergallo R, Minami Y, Ong DS, Hou J, Jia H, Soeda T, Hu S, Zhang S, Lee H, Yu B, Jang IK.
Changes in coronary plaque morphology in patients with acute coronary syndrome versus stable angina pectoris after initiation of statin therapy.
Coron Artery Dis. 27:629-635, 2016.

10. Higuma T, Soeda T, Yamada M, Yokota T, Yokoyama H, Izumiyama K, Nishizaki F, Minami Y, Xing L, Yamamoto E, Lee H, Okumura K, Jang IK.
Does Residual Thrombus After Aspiration Thrombectomy Affect the Outcome of Primary PCI in Patients With ST-Segment Elevation Myocardial Infarction?: An Optical Coherence Tomography Study.
JACC Cardiovasc Interv.9: 2002-2011, 2016

11. Higuma T, Soeda T, Yamada M, Yokota T, Yokoyama H, Nishizaki F, Xing L, Yamamoto E, Bryniarski K, Dai J, Lee H, Okumura K, Jang IK.
Coronary Plaque Characteristics Associated With Reduced TIMI (Thrombolysis in Myocardial Infarction) Flow Grade in Patients With ST-Segment-Elevation Myocardial Infarction: A Combined Optical Coherence Tomography and Intravascular Ultrasound Study.
Circ Cardiovasc Interv. 9: pii: e003913, 2016

12. Hou J, Xing L, Jia H, Vergallo R, Soeda T, Minami Y, Hu S, Yang S, Zhang S, Lee H, Yu B, Jang IK.
Comparison of Intensive Versus Moderate Lipid-Lowering Therapy on Fibrous Cap and Atheroma Volume of Coronary Lipid-Rich Plaque Using Serial Optical Coherence Tomography and Intravascular Ultrasound Imaging.
Am J Cardiol. 2015 Dec 13. pii: S0002-9149(15)02352-8.

13. Kagiyama N, Okura H, Matsue Y, Tamada T, Imai K, Yamada R, Kume T, Hayashida A, Neishi Y, Yoshida K.
Multiple Unfavorable Echocardiographic Findings in Takotsubo Cardiomyopathy Are Associated with Increased In-Hospital Events and Mortality.
J Am Soc Echocardiogr. 2016 Oct 11. pii: S0894-7317(16)30430-8

14. Kagiyama N, Okura H, Tamada T, Imai K, Yamada R, Kume T, Hayashida A, Neishi Y, Kawamoto T, Yoshida K.
Impact of right ventricular involvement on the prognosis of takotsubo cardiomyopathy.
Eur Heart J Cardiovasc Imaging. 17:210-6, 2016

15. Kume T, Okura H, Yamada R, Koyama T, Fukuhara K, Goryo Y, Kamata Y, Okamoto H, Tamada T, Imai K, Neishi Y, Uemura S.
In vivo assessment of vasa vasorum neovascularization using intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
J Cardiol. 2016 Oct 25. pii: S0914-5087(16)30222-2.

16. Kimura Y, Tanaka N, Okura H, Yoshida K, Akabane M, Takayama T, Hirayama A, Tada T, Kimura T, Takano H, Mizuno K, Inami T, Yoshino H, Yamashina A.
Characterization of real-world patients with low fractional flow reserve immediately after drug-eluting stents implantation.
Cardiovasc Interv Ther. 31:29-37, 2016

17. Kume T, Okura H, Yamada R, Koyama T, Fukuhara K, Kawamura A, Imai K, Neishi Y, Uemura S.
Detection of Plaque Neovascularization by Optical Coherence Tomography: Ex Vivo Feasibility Study and In Vivo Observation in Patients With Angina Pectoris.
J Invasive Cardiol. 28:17-22, 2016

18. Kume T, Okura H, Yamada R, Koyama T, Fukuhara K, Goryo Y, Kamata Y, Okamoto H, Tamada T, Imai K, Neishi Y, Uemura S.
In vivo assessment of vasa vasorum neovascularization using intravascular ultrasound: A comparison between acute coronary syndrome and stable angina pectoris.
J Cardiol. 2016 Oct 25. pii: S0914-5087(16)30222-2. doi: 10.1016/j.jjcc.2016.09.013. [Epub ahead of print]

1. Kumazawa T, Nishimura K, Katagiri N, Hashimoto S, Hayashi Y, Kimura K.
Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A.
Sci Rep. 5:10854, 2015.

2. Kurokawa M, Uemura S, Watanabe M, Dote Y, Sugawara Y, Goryo Y, Ueda T, Okayama S, Kayashima M, Saito Y.
Changes in the reference lumen size of target lesions before and after coronary stent implantation: Evaluation with frequency domain optical coherence tomography.
Int J Cardiol Heart Vasc. 2015 Jun 17;8:122-127. doi: 10.1016/j.ijcha.2015.06.003. eCollection 2015 Sep 1.

3. Matsui M, Samejima K, Takeda Y, Tanabe K, Morimoto K, Okamoto K, Tagawa M, Onoue K, Okayama S, Kawata H, Kawakami R, Akai Y, Saito Y.
Prognostic Impact of Placental Growth Factor on Mortality and Cardiovascular Events in Dialysis Patients.
Am J Nephrol. 42: 117-125, 2015.

4. Matsui M, Uemura S, Takeda Y, Samejima K, Matsumoto T, Hasegawa A Tsushima H, Hoshino E, Ueda T, Morimoto K, Okamoto K, Okada S, Onoue K, Okayama S, Kawata H, Kawakami R, Maruyama N, Akai Y, Iwano M, Shiiki H, Saito Y, for the NARA-CKD investigators.
Placental Growth Factor As A Predictor Of Cardiovascular Events In Patients With Chronic Kidney Disease from the Novel Assessment of Risk management for Atherosclerotic diseases in Chronic Kidney Disease (NARA-CKD) Study.
J Am Soc Nephrol. 26:2871-81, 2015.

5. Mizuno R, Yamagami S, Higashi T, Nakada Y, Takeda Y, Okayama S, Fujimoto S, Saito Y.
Major noncardiac surgery is a risk factor for rapid hemodynamic progression of non-rheumatic aortic stenosis.
Circ J.79:867-72,2015.

6. Nakada Y, Okayama S, Nakano T, Ueda T, Takeda Y, Kawakami R, Horii M, Uemura S, Fujimoto S, Saito Y.
Echocardiographic characteristics of patients with acute heart failure requiring tolvaptan: a retrospective study.
Cardiovascular Ultrasound. 13:27, 2015.

7. Neishi Y, Okura H, Kume T, Fukuhara K, Yamada R, Yoshida K.
Prediction of chronic vessel enlargement by a novel intravascular ultrasound finding.
Circ J. 79:607-12, 2015.

8. Okayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T, Sugawara Y, Matsumoto T, Sung JH, Nishida T, Uemura S, Saito Y.
Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography.
Heart Vessels. 30:28-35,2015.

9. Saito Y, Watanabe M, Aonuma K, Hirayama A, Tamaki N, Tsutsui H, Murohara T, Ogawa H, Akasaka T, Yoshimura M, Sato A, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K; CINC-J study investigators.
Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
Circ J. 79:1624-30, 2015.

10. Soeda T, Uemura S, Park SJ, Jang Y, Lee S, Cho JM, Kim SJ, Vergallo R, Minami Y, Ong DS, Gao L, Lee H, Zhang S, Yu B, Saito Y, Jang IK.
Incidence and Clinical Significance of Post-Stent OCT Findings: One Year Follow-Up Study From a Multicenter Registry.
Circulation. 132: 1020-9, 2015.

11. Tagawa M, Ogata A, Hamano T.
Pre- and/or Intra-Operative Prescription of Diuretics, but Not Renin-Angiotensin-System Inhibitors, Is Significantly Associated with Acute Kidney Injury after Non-Cardiac Surgery: A Retrospective Cohort Study.
PLoS One.10: e0132507, 2015.

12. Ueda T, Kawakami R, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF.
Circ J. 79: 2209-15, 2015.

13. Ueda T, Kawakami R, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
Plasma Renin Activity Is a Strong and Independent Prognostic Indicator in Patients With Acute Decompensated Heart Failure Treated With Renin-Angiotensin System Inhibitors.
Circ J. 79:1307-14, 2015.

14. Watanabe M, Saito Y, Aonuma K, Hirayama A, Tamaki N, Tsutsui H, Murohara T, Ogawa H, Akasaka T, Yoshimura M, Sato A, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K; CINC-J study investigators.
Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
J Cardiol. 2015 Dec 18. pii: S0914-5087(15)00358-5.

1. Asakura M, Yamamoto H, Asai K, Hanatani A, Hirata KI, Hirayakma A, Kimura K, Kobayashi Y, Momomura SI, Nakagawa Y, Nishi Y, Saito Y, Satoh Y, Yamada T, Yamashina A, Yasuda S, Yoshikawa T, Kada A, Uesaka H, Kitakaze M; on behalf of the EARLIER investigators and study coordinators.
Rationale and Design of the Double-Blind, Randomized, Placebo-Controlled Multicenter Trial on Efficacy of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER).
Cardiovasc Drugs Ther. 29:179-85, 2015.

2. Fukuhara K, Okura H, Kume T, Yamada R, Neishi Y, Uemura S.
In-stent neointimal characteristics and late neointimal response after drug-eluting stent implantation: A preliminary observation.
J Cardiol. 2015 Aug 11. pii: S0914-5087(15)00208-7.

3. Fukuhara K, Okura H, Koyama T, Kume T, Neishi Y, Hayashida A, Yoshida K.
Feasibility of a novel atrioventricular delay optimization method using transmitral and pulmonary venous flow in patients with sequential ventricular pacing or cardiac resynchronization therapy.
J Echocardiogr. 13:52-8, 2015.

4. Gao L, Park SJ, Jang Y, Lee S, Kim CJ, Minami Y, Ong D, Soeda T, Vergallo R, Lee H, Yu B, Uemura S, Jang IK.
Comparison of Neoatherosclerosis and Neovascularization Between Patients With and Without Diabetes: An Optical Coherence Tomography Study.
JACC Cardiovasc Interv. 8:1044-52, 2015.

5. Gao L, Park SJ, Jang Y, Lee S, Tian J, Minami Y, Jia H, Ong D, Soeda T, Vergallo R, Lee H, Yu B, Uemura S, Jang IK.
Optical coherence tomographic evaluation of the effect of cigarette smoking on vascular healing after sirolimus-eluting stent implantation.
Am J Cardiol.115:751-7,2015.

6. Higuma T, Soeda T, Abe N, Yamada M, Yokoyama H, Shibutani S, Vergallo R, Minami Y, Ong DS, Lee H, Okumura K, Jang IK.
A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on Plaque Rupture, Plaque Erosion, and Calcified Nodule in Patients With ST-Segment Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes After Percutaneous Coronary Intervention.
JACC Cardiovasc Interv. 8:1166-76, 2015.

7. Imai K, Kawata M, Okura H, Uemura S.
Accessory mitral valve tissue with mitral complex structural abnormality.
J Echocardiogr. 13:76-78, 2015.

8. Imamaki H, Ishii A, Yokoi H, Kasahara M, Kuwabara T, Mori KP, Kato Y, Kuwahara T, Satoh M, Nakatani K, Saito Y, Tomosugi N, Sugawara A, Nakao K, Mukoyama M, Yanagita M, Mori K.
Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
PLoS One.10: e0132539, 2015.

9. Ishihara M, Fujino M, Ogawa H, Yasuda S, Noguchi T, Nakao K, Ozaki Y, Kimura K, Suwa S, Fujimoto K, Nakama Y, Morita T, Shimizu W, Saito Y, Tsujita K, Nishimura K, Miyamoto Y; J-MINUET investigators.
Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era　- Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET).
Circ J. 79:1643, 2015.

10. Jia H, Hu S, Uemura S, Park SJ, Jang Y, Prasad A, Lee S, Soeda T, Abtahian F, Vergallo R, Tian J, Lee H, Stone PH, Yu B, Jang IK.
Insights into the spatial distribution of lipid-rich plaques in relation to coronary artery bifurcations: an in-vivo optical coherence tomography study.
Coron Artery Dis.26:133-41,2015.

11. Katagiri N, Kuroda T, Kishimoto H, Hayashi Y, Kumazawa T, Kimura K.
The nucleolar protein nucleophosmin is essential for autophagy induced by inhibiting Pol I transcription.
Sci Rep. 2015 Mar 10;5:8903. doi: 10.1038/srep08903.

12. Kobayashi K, Tanaka T, Okada S, Morimoto Y, Matsumura S, Manio MC, Inoue K, Kimura K, Yagi T, Saito Y, Fushiki T, Inoue H, Matsumoto M, Nabeshima YI.
Hepatocyte β-Klotho regulates lipid homeostasis but not body weight in mice.
FASEB J. 2015 Oct 29.[Epub ahead of print]

13. Kobayashi Y, Okura H, Kume T, Miyamoto Y, Yamada R, Kobayashi Y, Fukuhara K, Koyama T, Neishi Y, Yoshida K.
Direct relationship of local C-reactive protein production and lipid pool characterized by integrated backscatter intravascular ultrasound: a preliminary observation.
Coron Artery Dis. 26, 425-31, 2015.

14. Koyama T, Okura H, Kume T, Fukuhara K, Neishi Y, Hayashida A, Kawamoto T, Yoshida K.
Calcified plaque ablated by rotational atherectomy visualised by optical coherence tomography.
EuroIntervention. 11:e1, 2015.

15. Matsue Y, Kagiyama N, Yoshida K, Kume T, Okura H, Suzuki M, Matsumura A, Yoshida K, Hashimoto Y.
Carperitide Is Associated With Increased In-Hospital Mortality in Acute Heart Failure: A Propensity Score-Matched Analysis.
J Card Fail. 21:859-64, 2015.

16. Minami Y, Ong DS, Uemura S, Wang Z, Aguirre AD, Mukhopadhyay S, Soeda T, Vergallo R, Jia H, Tian J, Hu S, Kim SJ, Park CB, Dauerman HL, Lee S, Jang IK.
Impacts of lesion angle on incidence and distribution of acute vessel wall injuries and strut malapposition after drug-eluting stent implantation assessed by optical coherence tomography.
Eur Heart J Cardiovasc Imaging. 16:1390-8, 2015.

17. Minami Y, Phipps JE, Hoyt T, Milner TE, Ong DS, Soeda T, Vergallo R, Feldman MD, Jang IK.
Clinical utility of quantitative bright spots analysis in patients with acute coronary syndrome: an optical coherence tomography study.
Int J Cardiovasc Imaging. 31: 1479-87, 2015.

18. Mizuta K, Sakabe M, Hashimoto A, Ioka T, Sakai C, Okumura K, Hattammaru M, Fujita M, Araki M, Somekawa S, Saito Y, Nakagawa O.
Impairment of endothelial-mesenchymal transformation during atrioventricular cushion formation in Tmem100 null embryos.
Dev Dyn. 244:31-42,2015.

19. Nishimura K, Kumazawa T, Kuroda T, Katagiri N, Tsuchiya M, Goto N, Furumai R, Murayama A, Yanagisawa J, Kimura K.
Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.
DCell Rep. 10:1310-23,2015.

20. Vergallo R, Aguirre AD, Abtahian F, Minami Y, Soeda T, Chatzizisis YS, Croce K, Jang IK.
Recurrent myocardial infarctions and premature coronary atherosclerosis in a 23-year-old man with antiphospholipid syndrome.
Thromb Haemost. 2015 Oct 1.[Epub ahead of print]

21. Yamada R, Yoshida K, Okura H.
Progression of cardiac allograft vasculopathy detected by optical coherence tomography.
Coron Artery Dis. 26, 459-60, 2015.

1. Horii M, Saito Y.
Author's reply.[Cardiomyopathy: progress in diagnosis and treatments. Topics: III. Diagnosis leading to selection of therapy: 2. Biomarker]
J Cardiol. 2014 Apr 8. pii: S0914-5087(14)00026-4. doi: 10.1016/j.jjcc.2014.01.008. [Epub ahead of print]

2. Matsui M, Takeda Y, Uemura S, Matsumoto T, Seno A, Onoue K, Tsushima H, Morimoto K, Soeda T, Okayama S, Somekawa S, Samejima K, Kawata H, Kawakami R, Nakatani K, Iwano M, Saito Y,
Suppressed Soluble Fms-Like Tyrosine Kinase-1 Production Aggravates Atherosclerosis in CKD : Evaluation by Circulating sFlt-1 Levels after Low-Dose Heparin Injection.
Kidney Int.85:393-403,2014.

3. Matsui M, Okayama S, Tsushima H, Samejima K, Kanki T, Hasegawa A, Morimoto K, Akai Y, Takano M, Uemura S, Ohbayashi C, Saito Y.
Therapeutic Benefits of Tocilizumab Vary in Different Organs of a Patient with AA Amyloidosis.
Case Rep Nephrol. 2014;2014:823093. doi: 10.1155/2014/823093. Epub.

4. Nakagawa H, Oberwinkler H, Nikolaev VO, Gabner B, Umbenauer S, Wagner H, Saito Y, Baba HA, Frantz S, Kuhn M.
Atrial Natriuretic Peptide Locally Counteracts the Deleterious Effects of Cardiomyocyte Mineralocorticoid Receptor Activation.
Circ Heart Fail. 7:814-21, 2014.

5. Nakagawa H, Okayama S, Kamon D, Nakano T, Onoue K, Kawakami R, Horii M, Sakaguchi Y, Uemura S, Takemura G, Saito Y.
Refractory high output heart failure in a patient with primary mitochondrial respiratory chain disease.
Intern Med. 53:315-9, 2014.

6. Okayama S, Tanaka K, Kawata H, Dote Y, Matsui M, Samejima K, Takeda Y, Uemura S, Saito Y
Evaluation of cardiac prognosis in hemodialysis patients by using coronary computed tomography angiography and thallium single photon emission computed tomography: a retrospective study Experimental & Clinical Cardiology in press.

7. Okayama S, Nakada Y, Uemura S, Saito Y.
Three different morphologies of inferior vena cava thrombosis: case reports.
Case Rep Vasc Med. 2014;2014:349213. doi: 10.1155/2014/349213. Epub 2014 Mar 4.

8. Okayama S, Sugimoto M, Nakano T, Onoue K, Sakaguchi Y, Uemura S, Saito Y
Cardiac amyloidosis incidentally detected using technetium-99m hydroxymethylene diphosphonate bone scintigraphy in a patient with prostate cancer IJC Heart & Vessels.

9. Okayama.S, Nakada Y, Uemura S, Saito Y.
Three different morphologies of inferior vena cava thrombosis.
Case Rep in Vasc Med. 2014; 2014: 349213. doi: 10. 1155/ 2014/ 349213. Epub 2014 Mar 4.

10. Onoue K, Nkano T, Saito Y.
Cardiomyopathy: progress in diagnosis and treatments.
Topics: III. Diagnosis leading to selection of therapy: 2. Biomarker Nihon Naika Gakkai Zasshi 103: 345-52, 2014

11. Sakan H, Nakatani K, Asai O, Imura A, Tanaka T, Yoshimoto S, Iwamoto N, Kurumatani N, Iwano M, Nabeshima Y, Konishi N, Saito Y.
Reduced renal α-Klotho expression in CKD patients and its effect on renal phosphate handling and vitamin D metabolism.
PLoS One.9: e86301, 2014.

12. Ueda T, Kawakami R, Sugawara Y, Okada S, Nishida T, Onoue K, Soeda T, Okayama S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.
J Am Heart Assoc. 3:e001174,2014.

13. Ueda T, Uemura S, Watanabe M, Sugawara Y, Soeda T, Okayama S, Takeda Y, Kawata H, Kawakami R, Saito Y.
Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation.
Coron Artery Dis. 25:384-91, 2014.

14. Ueda T, Kawakami R, Horii M, Sugawara Y, Matsumoto T, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y.
Noncardiovascular death, especially infection, is a significant cause of death in elderly patients with acutely decompensated heart failure.
J Card Fail.20:174-80, 2014.

15. Watanabe M, Uemura S, Sugawara Y, Ueda T, Soeda T, Takeda Y, Kawata H, Kawakami R, Saito Y.
Side branch complication after a single-stent crossover technique: prediction with frequency domain optical coherence tomography.
Coron Artery Dis. 25: 321-9, 2014.

1. Morita S, Mizuno Y, Harada E, Nakagawa H, Morikawa Y, Saito Y, Katoh D, Kashiwagi Y, Yoshimura M, Murohara T, Yasue H.
Differences and interactions between risk factors for coronary spasm and atherosclerosis--smoking, aging, inflammation, and blood pressure.
Intern Med. 2014;53(23):2663-70. Epub 2014 Dec 1.

2. Ogawa H, Matsui K, Saito Y, Sugiyama S, Jinnouchi H, Sugawara M, Masuda I, Mori H, Waki M, Yoshiyama M, Watada H.
Differences between rosuvastatin and atorvastatin in lipid-lowering action and effect on glucose metabolism in Japanese hypercholesterolemic patients with concurrent diabetes. Lipid-lowering with highly potent statins in hyperlipidemia with type 2 diabetes patients (LISTEN) study ?.
Circ J. 2014;78(10):2512-5. Epub 2014 Sep 2.

3. Mizuno R, Fujimoto S, Saito Y, Okamoto Y.
Detection of latent anthracycline-induced cardiotoxicity using left ventricular end-systolic wall stress-velocity of circumferential fiber-shortening relationship.
Heart Vessels. 2014 May;29(3):384-9. doi: 10.1007/s00380-013-0375-5. Epub 2013 Jun 19.

4. Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, Imai Y, Imaizumi T, Ishimitsu T, Ito M, Ito S, Itoh H, Iwao H, Kai H, Kario K, Kashihara N, Kawano Y, Kim-Mitsuyama S, Kimura G, Kohara K, Komuro I, Kumagai H, Matsuura H, Miura K, Morishita R, Naruse M, Node K, Ohya Y, Rakugi H, Saito I, Saitoh S, Shimada K, Shimosawa T, Suzuki H, Tamura K, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S, Umemura S; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension.
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).
Hypertens Res. 37:253-387, 2014.

5. Tian J, Ren X, Vergallo R, Xing L, Yu H, Jia H, Soeda T, McNulty I, Hu S, Lee H, Yu B, Jang IK.
Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study.
J Am Coll Cardiol. 63:2209-1664, 2014.

6. Tian J, Dauerman H, Toma C, Samady H, Itoh T, Kuramitsu S, Domei T, Jia H, Vergallo R, Soeda T, Hu S, Minami Y, Lee H, Yu B, Jang IK.
Prevalence and characteristics of TCFA and degree of coronary artery stenosis: an OCT, IVUS, and angiographic study.
J Am Coll Cardiol. 64:672-80, 2014.

7. Vergallo R, Ren X, Yonetsu T, Kato K, Uemura S, Yu B, Jia H, Abtahian F, Aguirre AD, Tian J, Hu S, Soeda T, Lee H, McNulty I, Park SJ, Jang Y, Prasad A, Lee S, Zhang S, Porto I, Biasucci LM, Crea F, Jang IK.
Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study.
Am Heart J. 167: 59-67, 2014.

8. Wang Z, Jia H, Tian J, Soeda T, Vergallo R, Minami Y, Lee H, Aguirre A, Fujimoto JG, Jang IK.
Computer-aided image analysis algorithm to enhance in vivo diagnosis of plaque erosion by intravascular optical coherence tomography.
Circ Cardiovasc Imaging. 7: 805-10, 2014

1. Morikawa Y, Mizuno Y, Harada E, Katoh D, Kashiwagi Y, Morita S, Yoshimura M, Uemura S, Saito Y, Yasue H
Aerobic interval exercise training in the afternoon reduces attacks of coronary spastic angina in conjunction with improbvement in endothelial function, oxidative stress, and inflammation.
Coron Artery Dis. 24: 177-82, 2013.

2. Horii M, Matsumoto T, Uemura S, Sugawara Y, Takitsume A, Ueda T, Nakagawa H, Nishida T, Soeda T, Okayama S, Somekawa, Ishigami K, Takeda Y, Kawata H, Kawakami R, Saito Y.
Prognostic value of B-type natriuretic peptide (BNP) and its amino-terminal proBNP fragment for cardiovascular events with stratification by renal function.
J Cardiol. 61: 410-6, 2013.

3. Matsui M, Okayama S, Samejima K, Saito Y.
Unforeseen renal pathological findings in a patient with type 2 cardiorenal syndrome who died after four years of continuous ambulatory peritoneal dialysis.
BMJ Case Rep. 2013 Jan 24;2013. doi:pii: bcr2012008103. 10.1136/bcr-2012-008103.

4. Matsumoto T, Uemura S, Takeda Y, Matsui M, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Ishigami K, Onoue K, Kawata H, Kawakami R, Horii M, Saito Y
An Elevated Ratio of Placental Growth Factor to Soluble Fms-Like Tyrosine Kinase-1 Predicts Adverse Outcomes in Patients with Stable Coronary Artery Disease.
Intern Med. 52: 1019-27, 2013.

5. Nakatani K, Yoshimoto S, Asai O, Sakan H, Terada M, Saito Y, Nose M, Iwano M, Konishi N
Enhanced expression of the soluble from of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice Immun Inflamm Dis.
2013 Oct;1(1):37-46. doi: 10.1002/iid3.6. Epub.

6. Okada S, Morimoto T, Ogawa H, Sakuma M, Soezima H, Nakayama M, Sugiyama S, Jinnouchi H, Waki M, Doi N, Horii M, Kawata H, Somekawa S, Soeda T, Uemura S, Saito Y
Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
Circ. J. 2013 Nov 25;77(12):3023-8. Epub 2013 Sep 13.

7. Okayama S, Nakano T, Uemura S, Fujimoto S, Somekawa S, Watanabe M, Nakajima T, Saito Y
Evaluation of left ventricular diastolic function by fractional area change using cine cardiovascular magnetic resonance: a feasibility study.
J Cardiovasc Magn Reson.

8. Okayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T, Sugawara Y, Matsumoto T, Sung JH, Nishida T, Uemura S, Saito Y
Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography.
Heart Vessels. 2013 Dec 11. [Epub ahead of print]

9. Okayama S, Uemura S, Saito Y.
Evaluation of epicardial and intra-myocardial fat in a patient with mi tochondrial cardiomyopathy.
Int J Cardiol. 167: e43-5, 2013.

10. Okayama S, Uemura S, Saito Y.
Hypertrophic cardiomyopathy and mesenteric venous thrombosis in a patient with Klinefelter syndrome.
Int J Cardiol. 166: e50-2, 2013.

11. Soeda T, Uemura S, Saito Y, Mizuno K, Jang IK.
Optical Coherence Tomography and Coronary Plaque Characterization.
J Jpn Coron Assoc. 19: 307-314, 2013.

12. Ueda T, Kawakami R, Horii M, Sugawara Y, Matsumoto T, Okada S, Nishida T, Soeda T, Okayama S, Somekawa S, Takeda Y, Watanabe M, Kawata H, Uemura S, Saito Y
High mean corpuscular volume (MCV) is a new predictor of prognosis in patients with acute decompensated heart failure.
Circ. J. 77: 2766-71, 2013.

13. Yamano S, Horii M, Takami T, Sakuma M, Morimoto T, Okada S, Taoka T, Kichikawa K, Sasamura H, Itoh H, Furuya Y, Ueno S, Imamura T, Sugiyama S, Ogawa H, Saito Y.
Comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): Rationale, design, and methodology.
Int J Stroke, 2013 Jul 9. doi: 10.1111/ijs.12085. [Epub ahead of print]

1. Kubo T, Akasaka T, Shite J, Suzuki T, Uemura S, Yu B, Kozuma K, Kitabata H, Shinke T, Habara M, Saito Y, Hou J, Suzuki N, Zhang S.
OCT compared with IVUS in a coronary lesion assessment: the OPUS-CLASS study.
JACC Cardiovasc Imaging. 2013 Oct;6(10):1095-1104. doi: 10.1016/j.jcmg.2013.04.014. Epub 2013 Sep 4.

2. Soejima H, Ogawa H, Morimoto T, Nakayama M, Okada S, Sakuma M, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Waki M, Saito Y; JPAD Trial Investigators.
Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.
J Cardiol. 2013 Sep;62(3):165-70. doi: 10.1016/j.jjcc.2013.03.015. Epub 2013 Jun 16.

3. Arimura T, Onoue K, Takahashi-Tanaka Y, Ishikawa T, Kuwahara M, Setou M, Shigenobu S, Yamaguchi K, Bertrand AT, Machida N, Takayama K, Fukusato M, Tanaka R, Somekawa S, Nakano T, Yamane Y, Kuba K, Imai Y, Saito Y, Bonne G, Kimura A.
Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Cardiovasc Res. 99: 382-94, 2013.

4. Hamm A, Veschini L, Takeda Y, Costa S, Delamarre E,Squadrito ML, Henze AT, Wenes M, Serneels J, Pucci F, Roncal C, Anisimov A, Alitalo K, De Palma M, Mazzone M.
PHD2 regulates arteriogenic macrophages through TIE2 signalling.
EMBO Mol Med. 5: 843-57, 2013.

1. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, Yoshimoto S, Samejima KI, Yamaguchi Y, Matsui M, Akai Y, Konishi N, Iwano M, Nabeshima Y, Saito Y.
Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion.
Kidney Int. 81(6):539-547, 2012.

2. Iwano M, Yamaguchi Y,Iwamoto T, Nakatani K, Matsui M, Kubo A, Akai Y, Mori T, Saito Y
Urinary FSP1 Is a Biomarker of Crescentic GN.
J Am Soc Nephrol. 23(2):209-214, 2012.

3. Kawata H, Uesugi Y, Soeda T, Takemoto Y, Sung JH, Umaki K, Kato K, Ogiwara K, Nogami K, Ishigami K, Horii M, Uemura S, Shima M, Tabata Y, Saito Y.
A new drug delivery system for intravenous coronary thrombolysis with thrombus-targeting and stealth activity recoverable by ultrasound.
J Am Coll Cardiol. 60(24):2550-2557, 2012.

4. Matsui M, Okayama S, Takitsume A, Morimoto K, Samejima K, Uemura S, Saito Y.
Heart failure associated with metastatic myocardial calcification in a hemodialysis patient with progressive calcification of the hand.
Cardiorenal Med. 2:251-255, 2012.

5. Mizuno R, Fujimoto S, Saito Y, Okamoto Y.
Optimal antihypertensive level for improvement of coronary microvascular dysfunction: the lower, the better?
Hypertension. 60(2):326-332, 2012.

6. Mori E, Akai Y, Matsumoto T, Kawaratani H, Horii M, Iwano M, Uemura S, Nonomura A, Fukui H, Saito Y.
Hepatic cyst infection in a healthy older male.
BMJ Case Rep. 2012 Mar 20;2012. pii: bcr0420114136. doi: 10.1136/bcr.04.2011.4136.

7. Nishida T, Nakajima T, Kaitani K, Takitsume A, Soeda T, Okayama S, Somekawa S, Takeda Y, Ishigami KI, Kawata H, Kawakami R, Horii M, Uemura S, Saito Y.
Non-contact mapping system accurately localizes right-sided accessory pathways in type B Wolff-Parkinson-White syndrome.
Europace. 14(5):752-760, 2012.

8. Okayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T, Sugawara Y, Matsumoto T, Sung JH, Nishida T, Uemura S, Saito Y
Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography.
Heart Vessels. 2013 Dec 11. [Epub ahead of print]

9. Okayama S, Seno A, Soeda T, Takami Y, Kawakami R, Somekawa S, Ishigami K, Takeda Y, Kawata H, Horii M, Uemura S, Saito Y
Optimization of energy level for coronary angiography with dual-energy and dual-source computed tomography.
Int J Cardiovasc Imaging. 28(4):901-909, 2012.

10. Okayama S, Soeda T, Takami Y, Kawakami R, Somekawa S, Uemura S, Saito Y.
The influence of effective energy on computed tomography number depends on tissue characteristics in monoenergetic cardiac imaging.
Radiol Res Pract. 2012;2012:150980. doi: 10.1155/2012/150980. Epub 2012 Oct 9.

11. Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, Yamaguchi Y, Matsui M, Akai Y, Toyoda M, Iwano M, Saito Y.
Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Nephron Clin Pract. 120(1):c1-7, 2012

12. Somekawa S, Imagawa K, Hayashi H, Sakabe M, Ioka T, Sato GE, Inada K, Iwamoto T, Mori T, Uemura S, Nakagawa O, Saito Y
Tmem100, an ALK1 receptor signaling-dependent gene essential for arterial endothelium differentiation and vascular morphogenesis.
PNAS.109(30):12064-12069, 2012.

13. Takami T, Yamano S, Okada S, Sakuma M, Morimoto T, Hashimoto H, Somekawa S, Saito Y.
Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure.
Vasc Health Risk Manag. 8:169-176, 2012.

14. Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y
Thin-Cap Fibroatheroma and Microchannel Findings in Optical Coherence Tomography Correlate with Subsequent Progression of Coronary Atheromatous Plaques.
Eur Heart J. 33(1):78-85, 2012.

1. Doi M, Matsui H, Takeda Y, Saito Y, Takeda M, Matsunari Y, Nishio K, Shima M, Banno F, Akiyama M, Kokame K, Miyata T, Sugimoto M.
ADAMTS13 safeguards the myocardium in a mouse model of acute myocardial infarction.
Thromb Haemost. 108(6):1236-1238, 2012.

2. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK.
Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study.
Circ Cardiovasc Imaging. 5(4):433-440, 2012.

3. Katoh D, Mizuno Y, Harada E, Ito T, Morikawa Y, Nakagawa H, Saito Y, Yoshimura M, Yasue H.
High incidence of provoked coronary spasm in the presence of a stent after myocardial infarction: therapeutic and prognostic implications.
Coron Artery Dis. 23(3):141-145, 2012.

4. Leite de Oliveira R, Deschoemaeker S, Henze AT, Debackere K, Finisguerra V, Takeda Y, Roncal C, Dettori D, Tack E, Jonsson Y, Veschini L, Peeters A, Anisimov A, Hofmann M, Alitalo K, Baes M, D'hooge J, Carmeliet P, Mazzone M.
Gene-targeting of phd2 improves tumor response to chemotherapy and prevents side-toxicity.
Cancer Cell. 22(2):263-277, 2012.

5. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Raber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G; International Working Group for Intravascular Optical Coherence Tomography (IWG-IVOCT).
Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation.
J Am Coll Cardiol. 59(12):1058-1072, 2012.

6. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, Lee H, Zhang S, Uemura S, Jang Y, Kang SJ, Park SJ, Lee S, Yu B, Kakuta T, Jang IK.
Predictors for neoatherosclerosis: a retrospective observational study from the optical coherence tomography registry.
Circ Cardiovasc Imaging. 5(5):660-666, 2012.

7. Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Uemura S, Yu B, Kakuta T, Jang IK.
Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.
Am J Cardiol. 110(7):933-939, 2012.

1. Kubo A, Stull R, Takeuchi M, Bonham K, Gouon-Evans V, Sho M, Iwano M, Saito Y, Keller G, Snodgrass R
Pdx1 and Ngn3 Overexpression Enhances Pancreatic Differentiation of Mouse ES Cell-Derived Endoderm Population.
PLoS One. 6(9):e24058, 2011.

2. Maisel AS, Nakao K, Ponikowski P, Peacock WF, Yoshimura M, Suzuki T, Tsutamoto T, Filippatos GS, Saito Y, Seino Y, Minamino N, Hirata Y, Mukoyama M, Nishikimi T, Nagai R
Japanese-Western consensus meeting on biomarkers.
Int Heart J. 52(5):253-265, 2011.

3. Morikawa Y, Uemura S, Ishigami K, Soeda T, Okayama S, Takemoto Y, Onoue K, Somekawa S, Nishida T, Takeda Y, Kawata H, Horii M, Saito Y
Morphological features of coronary arteries in patients with coronary spastic angina: Assessment with intracoronary optical coherence tomography.
Int J Cardiol. 146(3):334-340, 2011.

4. Okada S, Morimoto T, Ogawa H, Kanauchi M, Nakayama M, Uemura S, Doi N, Jinnouchi H, Waki M, Soejima H, Sakuma M, Saito Y;for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators.
Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetic Management: A Subanalysis of the JPAD Trial.
Diabetes Care. 34(6):1277-1283, 2011.

5. Okayama S, Seno A, Soeda T, Takami Y, Horii M, Uemura S, Saito Y
Myocardial hypoperfusion detected by cardiac computed tomography in an adult patient with heart failure after classic repair for corrected transposition of the great arteries.
Acta Cardiologica. 66(4):535-536, 2011.

6. Okayama S, Ayako S, Somekawa S, Uemura S, Kubota Y, Saito Y
Feasibility of dual gradient-echo in-phase and opposed-phase magnetic resonance imaging for the evaluation of epicardial fat.
Acta Radiol. 52(7):723-729, 2011.

7. Okayama S, Soeda T, Seno A, Watanabe M, Nakajima T, Uemura S, Saito Y
Rare Concurrence of Apical Hypertrophic Cardiomyopathy and Effusive Constrictive Pericarditis.
Open Cardiovasc Med J. 5:99-102, 2011.

8. Okayama S, Uemura S, Soeda T, Onoue K, Somekawa S, Ishigami K, Watanabe M, Nakajima T, Fujimoto S, Saito Y
Clinical significance of papillary muscle late enhancement detected via cardiac magnetic resonance imaging in patients with single old myocardial infarction.
Int J Cardiol. 146(1):73-79, 2011.

9. Saito Y, Kishimoto I, Nakao K
Roles of guanylyl cyclase-A signaling in the cardiovascular system.
Can J Physiol Pharmacol. 89(8):551-556, 2011.

10. Saito Y, Morimoto T, Ogawa H, Nakayama M, Uemura S, Doi N, Jinnouchi H, Waki M, Soejima H, Sugiyama S, Okada S, Akai Y
Low-dose Aspirin Therapy in Patients With Type 2 Diabetes Mellitus and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD Trial.
Diabetes Care. 34(2):280-285, 2011.

11. Sakan H, Okayama S, Uemura S, Somekawa S, Ishigami K, Takeda Y, Kawata H, Horii M, Fujimoto S, Saito Y
Atrial right-to-left shunt without pulmonary hypertension in a patient with biventricular non-compaction cardiomyopathy accompanied by ventricular and atrial septal defects.
Intern Med. 50(16):1747-1751, 2011.

12. Soeda T, Okayama S, Seno A, Kawakami R, Somekawa S, Takeda Y, Uemura S, Saito Y.
Contrast-enhanced computed tomographic and echocardiographic detection of intra-aortic free floating thrombus causing acute myocardial infarction
J Cardiovasc Comput Tomogr. 5(1):63-65, 2011.

13. Soeda T, Uemura S, Morikawa Y, Ishigami K, Okayama S, Hee SJ, Nishida T, Onoue K, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y.
Diagnostic accuracy of dual-source computed tomography in the characterization of coronary atherosclerotic plaques: comparison with intravascular optical coherence tomography.
Int J Cardiol. 148(3):313-318, 2011 Epub 2009 Dec 11.

14. Soeda T, Uemura S, Okayama S, Kawakami R, Sugawara Y, Nakagawa H, Matsumoto T, Sung JH, Nishida T, Senoo A, Somekawa S, Takeda Y, Ishigami K, Kawata H, Horii M, Saito Y
Intensive lipid-lowering therapy with rosuvastatin stabilizes lipid-rich coronary plaques. -Evaluation using dual-source computed tomography.-.
Circ J. 75(11):2621-2627, 2011.

15. Takami T, Saito Y.
Effects of smoking cessation on central blood pressure and arterial stiffness.
Vasc Health Risk Manag. 7:633-638, 2011.

16. Takami T, Saito Y
Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index:the AORTA study.
Vascular Health and Risk Management. 7:383-390, 2011.

17. Takeda Y, Costa S, Delamarre E, Roncal C, Leite de Oliveira R, Squadrito ML, Finisguerra V, Deschoemaeker S, Bruyere F, Wenes M, Hamm A, Serneels J, Magat J, Bhattacharyya T, Anisimov A, Jordan BF, Alitalo K, Maxwell P, Gallez B, Zhuang ZW, Saito Y, Simons M, De Palma M, Mazzone M
Macrophage Skewing by PHD2 Haplodeficiency Prevents Ischemia by Inducing Arteriogenesis.
Nature. 479(7371):122-126, 2011.

18. Waki ML, Onoue K, Takahashi T, Goto K, Saito Y, Inami K, Makita I, Angata Y, Suzuki T, Yamashita M, Sato N, Nakamura S, Yuki D, Sugiura Y, Zaima N, Goto-Inoue N, Hayasaka T, Shimomura Y, Setou M
Investigation by imaging mass spectrometry of biomarker candidates for aging in the hair cortex.
PLoS One. 6(10):e26721, 2011.

19. Zaima N, Sasaki T, Tanaka H, Cheng XW, Onoue K, Hayasaka T, Goto-Inoue N, Enomoto H, Unno N, Kuzuya M, Setou M.
Imaging mass spectrometry-based histopathologic examination of atherosclerotic lesions.
Atherosclerosis. 217(2):427-432, 2011.

1. Harada K, Akai Y, Sakan H, Yamaguchi Y, Nakatani K, Iwano M, Saito Y
Resolution of mesangial light chain deposits 3 years after high-dose melphalan with autologous peripheral blood stem cell transplantation.
Clin Nephrol. 74(5):384-348, 2010.

2. Harada K, Miyamoto Y, Morisaki H, Ohta N, Yamanaka I, Kokubo Y, Makino H, Harada-Shiba M, Okayama A, Tomoike H, Okamura T, Saito Y, Yoshimasa Y, and Morisaki T
A novel Thr56Met mutation of the autosomal recessive hypercholesterolemia gene associated with hypercholesterolemia.
J Atheroscler Thromb. 26;17(2):131-140, 2010.

3. Kubo A, Kim Y. H, Irion S, Kasuda S, Takeuchi M, Ohashi K, Iwano M, Dohi Y, Saito Y, Snodgrass R, Keller G
The Homeobox Gene HEX Regulates Hepatocyte Differentiation from ES cell-Derived Endoderm.
Hepatology. 51(2):633-641, 2010.

4. Li Y, Saito Y, Kuwahara K, Rong X, Kishimoto I, Harada M, Horiuchi M, Murray M, Nakao K
Vasodilator therapy with hydralazine induces angiotensin AT receptor-mediated cardiomyocyte growth in mice lacking guanylyl cyclase-A.
Br J Pharmacol. 159(5):1133-1142, 2010.

5. Nakatani K, Yoshimoto S, Iwano M, Asai O, Samejima K, Sakan H, Terada M, Hasegawa H, Nose M, Saito Y.
Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models.
Am J Physiol Renal Physiol. 299(1):F207-216, 2010.

6. Okada S, Hiuge A, Makino H, Nagumo A, Takaki H, Konishi H, Goto Y, Yoshimasa Y, Miyamoto Y
Effect of exercise intervention on endothelial function and incidence of cardiovascular disease in patients with type 2 diabetes.
J Atheroscler Thromb. 17(8):828-833, 2010.

7. Okada S, Kozuka C, Masuzaki H, Yasue S, Ishii-Yonemoto T, Tanaka T, Yamamoto Y, Noguchi M, Kusakabe T, Tomita T, Fujikura J, Ebihara K, Hosoda K, Sakaue H, Kobori H, Ham M, Lee YS, Kim JB, Saito Y, Nakao K
Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity.
Metabolism. 59(9):1241-1251, 2010.

8. Okayama S, Fujimoto S, Tsutsumi T, Onoue K, Horii M, Uemura S, Sakaguchi Y, and Saito Y
A pediatric case of hypertrophic cardiomyopathy with mid-ventricular obstruction incidentally detected by electrocardiography.
JC Cases. 1(2):67-70, 2010.

9. Okayama S, Kawata H, Sung JH, Okada S, Nishida T, Onoue K, Soeda T, Uemura S, and Saito Y
Dual-single photon emission computed tomography and contrast-enhanced magnetic resonance imaging to evaluate dissimilar features of apical hypertrophic cardiomyopathy.
Cardiol J. 17(3):306-311, 2010.

10. Okayama S, Uemura S, Soeda T, Horii M, Saito Y
Role of cardiac computed tomography in planning and evaluating percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
J Cardiovasc Comput Tomogr. 4(1):62-65, 2010.

11. Okayama S, Uemura S, Soeda T, Seno A, Onoue K, Ishigami K, Horii M, Saito Y
Congenital isolated biventricular diverticula evaluated by cardiac computed tomography and magnetic resonance imaging.
Heart Lung Circ. 19(10):630-632, 2010.

12. Okayama S, Uemura S, Sugimoto H, Enomoto S, Onoue K, Omori S, Soeda T, Somekawa S, Ishigami K, Watanabe M, Nakajima T, Kubota Y, Saito Y
Dual Gradient-echo In-phase and Opposed-phase Magnetic Resonance Imaging to Evaluate Lipomatous Metaplasia in Patients with Old Myocardial Infarction.
Magn Reson Med Sci. 9(2):85-89, 2010.

13. Okayama S, Uemura S, Watanabe M, Morikawa Y, Onoue K, Soeda T, Iwama H, Somekawa S, Takeda Y, Uramoto H, Kobayashi Y, Saito Y
Novel application of black-blood echo-planar imaging to the assessment of myocardial infarction.
Heart and Vessel. 25(2):104-112, 2010.

14. Onoue K, Zaima N, Sugiura Y, Isojima T, Okayama S, Horii M, Akai Y, Uemura S, Takemura G, Sakuraba H, Sakaguchi Y, Setou M, Saito Y.
Imaging Mass Spectrometry to Accurately Diagnose Fabry’s Disease.
Circ J. 24;75(1):221-223, 2010.

15. Saito Y
Still Searching for a New Therapeutic Strategy for Acute Myocardial Infarction.
Circ J. 25;74(11):2290-2292, 2010.

16. Soejima H, Morimoto T, Saito Y, Ogawa H
Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus. Analyses from the JPAD, POPADAD and AAA trials.
Thromb Haemost. 104(6):1085-1088, 2010.

17. Uemura S, Onoue K, Saito Y
Response to Letter Regarding Article, ''Reduction of Circulating Soluble fms-Like Tyrosine Kinase-1 Plays a Significant Role in Renal Dysfunction-Associated Aggravation of Atherosclerosis''
Circulation. 122:e417, 2010.

18. Uesugi Y, Kawata H, Jo J, Saito Y, Tabata Y
An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy.
J Control Release. 15;147(2):269-277, 2010.

19. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y.
Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects.
Biochem Biophys Res Commun. 30;398(3):513-518, 2010.

1. Ishigami K, Uemura S, Morikawa Y, Soeda T, Okayama S, Nishida T, Takemoto Y, Onoue K, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y
Long term follow-up of neointimal coverage of sirolimus-eluting stents: Evaluation with optical coherencetomography.
Circ J. 3(12):2300-2307, 2009.

2. Li Y, Saito Y, Kuwahara K, Rong X, Kishimoto I, Harada M, Adachi Y, Nakanishi M, Kinoshita H, Horiuchi M, Murray M, Nakao K
Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Endocrinology. 150(8):3759-3765, 2009.

3. Motoyama H, Ogawa S, Kubo A, Miwa S, Tagawa Y, Miyagawa S
In vitro reprogramming of adult hepatocytes into insulin-producing cells without viral vectors.
Biochem Biophys Res Commun. 385:123-128, 2009.

4. Morikawa Y, Uemura S, Ishigami K, Soeda T, Okayama S, Takemoto Y, Onoue K, Somekawa S, Nishida T, Takeda Y, Kawata H, Horii M, Saito Y
Morphological features of coronary arteries in patients with coronary spastic angina: Assessment with intracoronary optical coherence tomography.
Int J Cardiol. 146(3):334-340, 2011 Epub 2009 Aug 27.

5. Nakagawa H, Morikawa Y, Mizuno Y, Harada E, Ito T, Matsui K, Saito Y, Yasue H
Coronary Spasm Preferentially Occurs at Branch Points: An Angiographic Comparison With Atherosclerotic Plaque.
Circ Cardiovasc Intervent. 2:97-104, 2009.

6. Okayama S, Matsui M, Somekawa S, Iwano M, Saito Y
Non-contrast MRI for the evaluation of hydronephrotic and dysfunctioning kidney secondary to testicular cancer.
Ren Fail. 31(2):153-158, 2009.

7. Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Nishida T, Morikawa Y, Nakagawa H, Tsutsumi T, Sung J. H, Takemoto Y, Soeda T, Okayama S, Ishigami K, Kawata H, Horii M, Nakajima T, Saito Y
Usefulness of soluble Fms-like tyrosine kinase 1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
Am J Cardiol. 104(11):1478-1483, 2009.

8. Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, Nishida T, Morikawa Y, Takemoto Y, Asai O, Soeda T, Okayama S, Ishigami K, Nakatani K, Kawata H, Horii M, Nakajima T, Akai Y, Iwano M, Saito Y
Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Circulation. 15;120(24):2470-2477, 2009.

9. Somekawa S, Imagawa K, Naya N, Takemoto Y, Onoue K, Okayama S, Takeda Y, Kawata H, Horii M, Nakajima T, Uemura S, Mochizuki N, Saito Y
Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor.
Endocrinology. 50(7):3110-3117, 2009.

10. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y,Tabata Y, Saito Y, Nagai R, and Sata M
Periadventitial adipose tissue plays a critical role in vascular remodeling.
Circ Res. 105(9):906-911, 2009.

11. Takeda Y, Uemura S, Iwama H, Imagawa K, Nishida T, Onoue K, Takemoto Y, Soeda T, Okayama S, Somekawa S, Ishigami K, Takaoka M, Kawata H, Kubo A, Horii M, Nakajima T, Saito Y
Treatment with recombinant placental growth factor (PlGF) enhances both angiogensis and arteriogenesis and improves survival after myocardial infarction.
Circ J. 73(9):1674-1682, 2009.

12. Takemoto Y, Kawata H, Soeda T, Imagawa K, Somekawa S, Takeda Y, Uemura S, Matsumoto M, Fujimura Y, Jo J, Kimura Y, Tabata Y, Saito Y
Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
Arterioscler Thromb Vasc Biol. 29(6):857-862, 2009.

13. Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, Kubo A, Akai Y, Toyoda M, Kanauchi M, Eric G Neilson, SaitoY
Epithelial-mesenchymal transition as an explanation for podocyte depletion in diabetic nephropathy.
Am J Kidney Dis. 54(4):653-664, 2009.

1. Horii M, Uemura S, Uemura　M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y
Acute Myocardial Infarction as a Systemic Prothrombotic Condition Evidenced by Increased von Willebrand Factor Protein Over ADAMTS13 Activity in Coronary and Systemic Circulation.
Heart and Vessel. 23(5):301-307, 2008.

2. Harada K, Akai Y, Yamaguchi Y, Kimura K, Nishitani Y, Nakatani K, Iwano M, Saito Y
Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy.
Nephrol Dial Transplant. 23(10):3152-3159, 2008.

3. Harada K, Akai Y, Koyama S, Ikenaka Y, Saito Y
A case of autoimmune hepatitis exacerbated by the administration of etanercept in the patient with rheumatoid arthritis.
Clin Rheumatol. 27(8):1063-1066, 2008.

4. Kasuda S, Kubo A, Sakurai Y, Irion S, Ohashi K, Tatsumi K, Nakajima Y, Saito Y, Hakake K, Pipe SW, Shima M, Yoshioka A
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A.
J Thromb Haemost. 6(8):1352-1359, 2008.

5. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H
Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia.
Am Heart J. 156:1010-1018, 2008.

6. Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, Jinnouchi H, Sugiyama S, Saito Y
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
JAMA. 300(18):2134-2141, 2008.

7. Okayama S, Hirai T, Yamashita N, Somekawa S, Iwano M, Uemura S, Kanauchi M, Saito Y
Contrast-enhanced ultrasonography with Sonazoid for evaluation of renal microcirculation.
J Med Ultrasonics. 35:183-189, 2008.

8. Okayama S, Uemura S, Kawata H, Horii M, Saito Y
Continuing improvement of cardiac sympathetic activity on 123I-MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
J Nucl Cardiol. 15(5):e31-34, 2008.

9. Okayama S, Uemura S, Nishida T, Morikawa Y, Onoue K, Takemoto Y, Soeda T, Somekawa S, Ishigami K, Takeda Y, Horii M, Kawata H, Takaoka M, Nakajima T, Saito Y
Progression of non-culprit coronary artery atherosclerosis after acute myocardial infarction in comparison with stable angina pectoris.
J Atheroscler Thromb. 15(5):228-234, 2008.

10. Q Zhang, Saito Y, Naya N, Imagawa K, Somekawa S, Kawata H, Takeda Y, Uemura S, Kishimoto I, Nakao K
The Specific Mineralocorticoid Receptor Blocker Eplerenone Attenuates Left Ventricular Remodeling in Mice Lacking the Gene Encoding Guanylyl Cyclase-A
Hypertens Res. 31(6):1251-1256, 2008.

11. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, Ogawa H, Tayama S, Honda T, Hokimoto S, Ohshima S, Hokamura Y, Kugiyama K, Horie M, Yoshimura M, Harada M, Uemura S, Saito Y
Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
J Am Coll Cardiol. 51(18):1742-1748, 2008.

1. Higgins DF，Kimura K，Bernhardt WM，Shrimanker N，Akai Y，Hohenstein B，Saito Y, Johnson RS，Kretzler M，Cohen CD，Eckardt KU，Iwano M，Haase VH
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.
J Clin Invest. 117（12):3810-3820，2007.

2. Kanauchi M, Kanauchi K, Inoue T, Kimura K, Saito Y.
Surrogate markers of insulin resistance in assessing individuals with new categories "prehypertension" and "prediabetes".
Clin Chem Lab Med. 45(1):35-39, 2007.

3. Kawata H，Naya N，Takemoto Y，Uemura S，Nakajima T，Horii M，Takeda Y，Fujimoto S，Yamashita A，Asada Y，Saito Y
Ultrasound accelerates thrombolysis of acutely induced platelet-rich thrombi similar to those in acute myocardial infarction.
Circ J. 71（10):1643-1648，2007．

4. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S; J-WIND investigators.
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
Lancet. 370 (9597):1483-1493, 2007.

5. Kimura K, Yamaguchi Y, Horii M, Kawata H, Yamamoto H, Uemura S, Saito Y.
ANP is Cleared Much Faster than BNP in Patients with Congestive Heart Failure.
Eur J Clin Pharmacol. 63(7):699-702, 2007.

6. Kuratomi S, Kuratomi A, Kuwahara K, Ishii TM, Nakao K, Saito Y, Takano M.
NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes.
Biochem Biophys Res Commun. 353(1):67-73, 2007.

7. Morimoto T，Nakayama M，Saito Y，Ogawa H
Aspirin for primary prevention of atherosclerotic disease in Japan.
J Atheroscler Thromb. 14(4):159-166，2007．

8. Nakatani K, Qu WM, Zhang MC, Fujii H, Furukawa H, Miyazaki T, Iwano M, Saito Y, Nose M, Ono M.
A Genetic Locus Controlling Aging-sensitive Regression of B Lymphopoiesis in an Autoimmune-prone MRL/lpr Strain of Mice.
Scand J Immunol. 66(6):654-661,2007.

9. Nakanishi M, Harada M, Kishimoto I, Kuwahara K, Kawakami R, Nakagawa Y, Yasuno S, Usami S, Kinoshita H, Adachi Y, Fukamizu A, Saito Y, Nakao K.
Genetic Disruption of Angiotensin II Type 1a Receptor Improves Long-Term Survival of Mice With Chronic Severe Aortic Regurgitation.
Circ J. 71(8):1310-1316, 2007.

10. Nishijima T, Nakayama M, Yoshimura M, Abe K, Yamamuro M, Suzuki S, Shono M, Sugiyama S, Saito Y, Miyamoto Y, Nakao K, Yasue H, Ogawa H.
The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm.
Pharmacogenet Genomics. 17(8):581-587, 2007.

11. Okayama S, Uemura S, Saito Y
Detection of infarct-related myocardial edema using cardiac diffusion-weighted magnetic resonance imaging.
Int J Cardiol. Dec 17, 2007.

12. Shimasaki Y, Saito Y, Yoshimura M, Kamitani S, Miyamoto Y, Masuda I, Nakayama M, Mizuno Y, Ogawa H, Yasue H, Nakao K.
The effects of long-term smoking on endothelial nitric oxide synthase mRNA expression in human platelets as detected with real-time quantitative RT-PCR.
Clin Appl Thromb Hemost. 13(1):43-51, 2007.

13. Saito Y.
Clinical pathology and treatment of Renin-Angiotensin system 1. Usefulness of blocking of the Renin-Angiotensin system in treatment of chronic heart failure.
Intern Med. 46(16):1291-1294, 2007.

14. Tatsumi T, Ashihara E, Yasui T, Matsunaga S, Kido A, Sasada Y, Nishikawa S, Hadase M, Koide M, Nakamura R, Irie H, Ito K, Matsui A, Matsui H, Katamura M, Kusuoka S, Matoba S, Okayama S, Horii M, Uemura S, Shimazaki C, Tsuji H, Saito Y, Matsubara H.
Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction.
Circ J. 71(8):1199-1207, 2007.

15. Yoshimoto S, Nakatani K, Iwano M, Asai O, Samejima K, Sakan H, Terada M, Harada K, Akai Y, Shiiki H, Nose M, Saito Y.
Elevated levels of fractalkine expression and accumulation of CD16＋monocytes in glomeruli of active lupus nephritis
Am J Kidney Dis. 50(1):47-58, 2007.

1. Iwama H, Naya N, Imagawa K, Takemoto Y, Asai O, Onoue K, Okayama S, Somekawa S, Kida Y, Takeda Y, Takaoka H, Kawata M, Horii M, Nakajima T, Doi N, Saito Y.
Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction.
J. Am. Coll. Cardiol. 47:1559-1567, 2006.

2. Imagawa K, Okayama S, Takaoka M, Kawata H, Naya N, Nakajima T, Horii M, Uemura S, Saito Y.
Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
J. Cardiovasc. Pharmacol. 47:133-138, 2006.

3. Kanauchi M, Kanauchi K, Kimura K, Inoue T, Saito Y.
Utility of elevated 2-hour postload plasma glucose as an alternative to elevated fasting glucose as a criterion for the metabolic syndrome.
Metabolism. 55:1323-1326, 2006.

4. Kanauchi M, Kanauchi K, Kimura K, Inoue T, Saito Y.
Associations of chronic kidney disease with the metabolic syndrome in non-diabetic elderly.
Nephrol Dial Transplant. 2006.

5. Kin T, Yamano S, Sakurai R, Kajitani M, Okahashi Y, Nishiura N, Saito Y, Ueno S.
Carotid Atherosclerosis is Associated with Brain Atrophy in Japanese Elders.
Gerontology. 53:1-6, 2006.

6. Mizuno R, Fujimoto S, Saito Y, Nakamura S.
Non-Invasive Quantitation of Myocardial Fibrosis Using Combined Tissue Harmonic Imaging and Integrated Backscatter Analysis in Dilated Cardiomyopathy.
Cardiology. 108:11-17, 2006.

7. Nakagawa Y, Kuwahara K, Harada M, Takahashi N, Yasuno S, Adachi Y, Kawakami R, Nakanishi M, Tanimoto K, Usami S, Kinoshita H, Saito Y, Nakao K.
Class II HDACs mediate CaMK-dependent signaling to NRSFin ventricular myocytes.
J. Mol. Cell Cardiol. 2006.

8. Nakayama M, Yoshimura M, Sakamoto T, Abe K, Yamamuro M, Shono M, Suzuki S, Nishijima T.
A -786T>C polymorphism in the endothelial nitric oxide synthase gene reduces serum nitrite/nitrate levels from the heart due to an intracoronary injection of acetylcholine.
Pharmacogenet. Genomics. 16:339-345, 2006.

9. Okayama S, Imagawa K, Noriyuki N, Iwama H, Somekawa S, Kawata H, Horii M, Nakajima T, Uemura S, Saito Y.
Blocking T-type Ca2+ channels with Efonidipine Decreased Plasma Aldosterone Concentration in Healthy Volunteers.
Hypertens. Res. 29:493-497, 2006.

10. Takaoka M, Uemura S, Kawata H, Imagawa K, Takeda Y, Nakatani K, Naya N, Horii M, Yamano S, Miyamoto Y, Yoshimasa Y, and Yoshihiko S.
Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery.
Arterioscler Thromb Vasc Biol. 26:2083-2089, 2006.

11. Watanabe M, Uemura S, Iwama H, Okayama S, Takeda Y, Kawata H, Horii M, Nakajima T, Hirohashi S, Kichikawa K, Ookura A, Saito Y.
Usefulness of 16-slice multislice spiral computed tomography for follow-up study of coronary stent implantation.
Circ. J. 70:691-697, 2006.

12. Yamamuro M, Yoshimura M, Nakayama M, Abe K, Shono M, Suzuki S, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H.
Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extracellular sodium.
Endocrinology. 147:1314-1321, 2006.

1. Abe K, Nakayama M, Yoshimura M, Nakamura S, Ito T, Yamamuro M, Sakamoto T, Miyamoto Y, Yoshimasa Y, Saito Y, Nakao K, Yasue H, Ogawa H.
Increase in the transcriptional activity of the endothelial nitric oxide synthase gene with fluvastatin: relation with the -786T>C polymorphism.
Pharmacogenet Genomics. 15:29-36, 2005.

2. Biju MP., Akai Y, Shrimanker N, Haase VH.
Protection of HIF-1-deficient primary renal tubular epithelial cells from hypoxia-induced cell death is glucose dependent.
Am. J. Physiol. Renal Physiol. 289:F1217-1226, 2005.

3. Danno D, Fujimoto S, Yamamoto Y, Mizuno R, Maeda K, Kanno M, Fujimoto T, Matsumura M, Nakamura S.
Influence of patient/doctor relationship on the non-attendence rate of general practice, and investigation of reason for hospital non-attendance.
General Medicine. 16:17-21, 2005．

4. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N.
Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway.
Mol. Cell Biol. 25:136-146，2005．

5. Fukuhara S, Tomita S, Nakatani T, Yutani C, Kitamura S.
Endogenous bone-marrow-derived stem cells contribute only a small proportion of regenerated myocardium in the acute infarction model.
J. Heart Lung Transplant. 24:67-72, 2005．

6. Hamano K, Katafuchi T, Kikumoto K, Minamino N.
Calcitonin receptor-stimulating peptide-1 regulates ion transport and growth of renal epithelial cell line LLC-PK1.
Biochem. Biophys. Res. Commun. 330: 75-80, 2005.

7. Harada K, Akai Y, Iwano M, Nakatani K, Nishino T, Fujimoto T, Shiiki H, Saito Y.
Tubulointerstitial macrophage infiltration in a patient with hypokalemic nephropathy and primary Sjogren's syndrome.
Clin Nephrol. 64: 387-390, 2005.

8. Kanauchi M, Kimura K, Kanauchi K, Saito Y.
Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals.
Int J Clin Pract. 59: 427-432, 2005.

9. Matsumura N, Yamamoto K, Hirohashi R, Kitano S.
Renal tuberculosis mimicking hydronephrosis.
Intern. Med. 44: 768-，2005．

10. Nakanishi M, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakagawa Y, Tanimoto K, Yasuno S, Usami S, Li Y, Adachi Y, Fukamizu A, Garders DL, Nakao K.
Role of natriuretic peptide receptor guanylyl cyclase-A in myocardial infarction evaluated using genetically engineered mice.
Hypertension. 46: 441-447, 2005.

11. Nishitani Y, Iwano M, Yamaguchi Y, Harada K, Nakatani K, Akai Y, Nishino T, Shiiki H, Kanauchi M, Saito Y, Neilson EG.
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN.
Kidney Int. 68:1078-1085, 2005.

12. Saito Y.
Hypoglycemic attack: A rare triggering factor for takotsubo cardiomyopathy.
Intern. Med. 44:171-172, 2005．

13. Shima Y, Iwano M, Yoshizaki K, Tanaka T, Kawase I, Nishimoto N.
All-trans-Retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice.
Nephron Exp Nephrol. 100:54-62, 2005.

14. Somekawa S, Fukuhara S, Nakaoka Y, Fujita H, Saito Y, Mochizuki N.
Enhanced functional gap junction neoformation by protein kinase A-dependent and epac-dependent signal downstream of cAMP in cardiac myocytes.
Circ. Res. 97:655-662, 2005.

15. Takahashi N, Saito Y, Kuwahara K, Harada M, Tanimoto K, Nakagawa Y, Kawakami R, Nakanishi M, Yasuno S, Usami S, Yoshimura A, Nakao K.
Hypertrophic responses to cardiotrophin-1 are not mediated by STAT3, but via a MEK5-ERK5 pathway in cultured cardiomyocytes.
J. Mol. Cell Cardiol. 38:185-192, 2005．

16. Tanimoto K, Saito Y, Hamanaka I, Kuwahara K, Harada M, Takanashi N, Kawakami R, Nakagawa Y, Nakanishi M, Adachi Y, Shirakami G, Fukuda K, Yoshimura A and Nakano K.
SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharide-induced left ventricular dysfunction in vivo.
Circ. J. 69:1412-1417, 2005.

17. Yamaji K, Fujimoto S, Ikeda Y, Masuda K, Nakamura S, Saito Y, Yutani C.
Apoptotic myocardial cell death in the setting of arrhythmogenic right ventricular cardiomyopathy.
Acta Cardiologica. 60:465-470, 2005.

18. Yamamuro M, Yoshimura M, Nakayama M, Abe K, Shono M, Suzuki S, Sakamoto T, Saito Y, Nakao K, Yasue H and Ogawa H.
Direct effects of aldosterone on cardiomyocytes in the presence of normal and elevated extrcellular sodium.
Endocrinology. 147:1314-1321, 2005.

1. Adachi Y, Imagawa J, Suzuki Y, Yogo K, Fukazawa M, Kuromaru O, Saito Y.
G-CSF treatment increase side population cell infiltration after myocardial infarction in mice.
J. Mol. Cell. Cardiol. 36:707-710, 2004.

2. Fujimoto S, Mizuno R, Saito Y, Nakamura S.
Clinical application of wave intensity for the treatment of essential hypertension.
Heart Vessels. 19: 19-22, 2004.

3. Iwano M, Neilson EG
Mechanisms of tubulointerstitial fibrosis.
Curr. Opin. Nephrol. Hypertens. 13:279-284, 2004．

4. Kanauchi M, Kimura K, Akai Y and Saito Y.
Insulin resistance and pancreatic beta-cell function in the patients with hypertensive kidney disease.
Nephrol. Dial. Transplant. 19: 2025-2029, 2004.

5. Kakui K, Ito H, Sagawa N, Yura S, Korita D, Takemura M, Miyamoto Y, Saito Y, Nakao K, Fujii S.
Augmented endothelial nitric oxide synthase (eNOS) protein ezpression in human pregnant myometrium:possible involvement of eNOS promoter activation by estrogen via both estrogen receptor (ER)α and ERβ.
Mol. Hum. Reprod. 2:115-122, 2004.

6. Kanauchi M, Kanauchi K, Hashimoto T, Saito Y
Metabolic syndrome and new category 'pre-hypertension' in a Japanese population.
Curr Med Res Opin. 20:1365-1370, 2004.

7. Kawakami R, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Nakagawa Y, Nakanishi M, Tanimoto K, Usami S, Yasuno S, Saito Y, Kinoshita H, Ogawa Y, Nakao K.
Overexpression of brain natriuretic peptide induces excessive matrix remodeling after acute myocardial infarction in mice.
Circ. 110:3306-3312, 2004.

8. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Hamanaka I, Takahashi N, Kawakami R, Tanimoto K, Nakagawa Y, Nakanishi M, Adachi Y, Garbers DL, Fukamizu A, Nakao K.
Androgen contributes to gender-related cardiac hypertrophy and fibrosis in mice lacking the gene encoding guanylyl cyclase-A.
Endocrinology. 145:951-958, 2004.

9. Nakatani K, Fujii H, Hasegawa H, Terada M, Arita N, MR. Ito, Ono M, Takahashi S, Saiga K, Yoshimoto S, Iwano M, Shiiki H, Saito Y, Nose M.
Endothelial adhesion molecules in glomerular lesions: association with their severity and diversity in lupus models.
Kidney Int. 65:1290-1300, 2004.

10. Nakashima T, Yamano S, Sasaki R, Minami S, Doi K, Yamamoto J, Takaoka M, Saito Y.
White-coat hypertension contributes to the presence of carotid arteriosclerosis.
Hypertens. Res. 27:739-745, 2004.

11. Nakamura S, Yoshimura M, Nakayama M, Ito T, Mizuno Y, Harada E, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H.
Possible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heart.
Circ. 110:1787-1793, 2004.

12. Nishizawa J, Matsumoto M, Sugita T, Matsuyama K, Tokuda Y, Yoshida K, Matsuo T, Okayama S, Fujimoto S and Saito Y.
Intravenous leiomyomatosis extending into the right ventricle association with pulmonary metastasis and extensive arteriovenous fistula.
J. Am. Coll. Surg. 198:842-843, 2004.

13. Suzuki S, Yoshimura M, Nakayama M, Mizuno Y, Harada E, Ito T, Nakamura S, Abe K, Yamamuro M, Sakamoto T, Saito Y, Nakao K, Yasue H, Ogawa H.
Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
Circ. 110:1387-1391, 2004.

14. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, Yokoyama H, Nishi S, Tomino Y, Kurokawa K, Sakai H.
Research Group on Progressive Renal Diseases in Japan.
Prognosis and risk factors for idiopathic membranous nephropathy with nephritic syndrome in Japan.
Kidney Int. 65:1400-1407, 2004.

15. Takeda Y, Mori T, Imabayashi H, Kiyono T, Gojo S, Miyoshi S, Hida N, Ita M, Segawa K, Ogawa S, Sakamoto M, Nakamura S, Umezawa A.
Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation.
J. Gene. Med. 6:833-845, 2004.

16. Uemura S, Watanabe M, Iwama H, Saito Y.
Extensive primary cardiac liposarcoma with multiple functional complications.
Heart. 90: e48-49, 2004.

1. Adachi Y, Saito Y, Kishimoto I, Harada M, Kuwahara K, Takahashi N, Kawakami R, Nakanishi M, Nakagawa Y, Tanimoto K, Saito Y, Yasuno S, Usami S, Iwai M, Horiuchi M, Nakao K.
Angiotensin type 2 reseptor deficiency exacerbates heart failure and reduces Servival following acute myocardial infarction in mice.
Circ. 107:2406-2408, 2003.

2. Kanauchi M, Nakajima M, Kanauchi K and Saito Y.
Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diabnosed type 2 deabetes mellitus.
Metabolism. 52:476-481, 2003.

3. Kanauchi M.
Validation of the oral glucose insulin sensitivity index to assess insulin sensitivity in Japanese subjects for use in clinical practice.
Eur J Clin Invest. 33:1022-1023, 2003．

4. Kanauchi M.
Obesity-related albuminuria and renal histology in patients with type 2 diabetes mellitus.
Nephrol Dial Transplant. 18:849-850, 2003．

5. Kanauchi M, Yamano S, Kanauchi K and Saito Y
Homeostasis model assessment of insulin resistance, quantitative insulin sensitivity　check index, and oral glucose insulin sensitivity index in nonobese, nondiabetic subjects with high-nomal blood pressure.
J. Clin. Endocrinol. Metab. 88: 3444-3446, 2003．

6. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y, Takahashi N, Adachi Y, Takemura G, Horie M, Miyamoto Y, Morisaki T, Kuratomi S, Noma A, Fujiwara H, Yoshimasa Y, Kinoshita H, Kawakami R, Kishimoto I, Nakanishi M, Usami S, Saito Y, Harada M and Nakao K.
NRSF regulates fetal cardiac gene program and maintains normal cardiac structure and funcution.
EMBO J. 22:6310-6321, 2003.

7. Nakayama M, Yoshimura M, Sakamoto T, Shimasaki Y, Nakamura S, Ito T, Abe K, Yamamuro M, Miyamoto Y, Saito Y, Nakao K, Yasue H and Ogawa H.
Synergistic interaction of T-786 → C polymorphism in the endothelial nitric oxide synthase gene and smoking for an enhanced risk for coronary spasm.
Pharmacogenetics. 13:683-688, 2003.

8. Takahashi N, Saito Y, Kuwahara K, Harada M, Kishimoto I, Ogawa Y, Kawakami R, Nakagawa Y, Nakanishi M and Nakao K.
Angiotensin II-induced ventricular hypertrophy and extracelluar signal-regulated kinase activation are suppressed in mice overexpressing brain natriuretic peptide in circulation.
Hypertens Res. 26:847-853, 2003.

1. Harada K, Akai Y, Kurumatani N, Iwano M and Saito Y.
Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study.
Nephron. 92:824-826, 2002.

2. Kanauchi M.
Cigarette smoking affects tubulointerstitial lesion in type 2 diabetes.
Diabetes. Care. 25:1486-1487, 2002.

3. Kanauchi M.
A new index of insulin sensitivity obtained from the oral glucose tolerance test applicable to advanced type 2 diabetes mellitus.
Diabetes Care. 25:1891-1892, 2002.

4. Kanauchi M, Akai Y and Hashimoto T.
Transferrinuria in type 2 diabetic patients with early nephropathy and tubulointerstitial injury.
Eur. J. Intern. Med. 13:190-193, 2002.

5. Kanauchi M, Akai Y and Hashimoto T.
Validation of simple indices to assess insulin sensitivity and pancreatic beta-cell function in patients with renal dysfunction.
Nephron. 92:713-715, 2002.

6. Kanauchi M, Motomiya K and Hashimoto T.
Insulin secretion and sensitivity in nonobese and obese Japanese patients with coronary artery disease.
Metabolism. 51:184-188, 2002.

7. Kanauchi M, Nishioka H and Hashimoto T.
Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy.
Nephron. 91:327-329, 2002.

8. Kanauchi M, Tsujimoto N and Hashimoto T.
Validation of simple indices to assess insulin sensitivity based on the oral blucose tolerance test in the Japanese population.
Diabetes. Res. Clin. Pract. 55:229-235, 2002.

9. Li Y, Kishimoto I, Saito Y, Harada M, Kuwahara K, Izumi T, Takahashi N, Kawakami R,Tanimoto K, Nakagawa Y, Nakanishi M, Adachi Y, Garbers DL, Fukamizu A, Nakao K.
Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
Circ. 106:1722-1728, 2002.

10. Mizuno Y, Yasue H, Yoshimura M, Fujii H, Yamamoto N, Nakayama M, Harada E, Sakamoto T, Nakamura S, Ito T, Shimasaki Y, Ogawa H, Saito Y and Nakao K.
Effects of perindopril on aldosterone production in the failing human heart.
Am J Coll Cardiol. 89:1197-1200, 2002.

11. Ogawa E, Saito Y, Kuwahara K, Harada M, Miyamoto Y, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Kishimoto I, Naruse Y, Mori N and Nakao K.
Fibronectin signaling stimulates BNP gene transcription by inhibiting neuron-restrictive silencer element-dependent repression.
Cardiovasc Res. 53:451-459, 2002.